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Peeling skin, leukonychia, acral punctate keratoses, cheilitis and knuckle pads with milia 
caused by loss-of-function mutations in calpastatin
Z Lin,2 D Nitoiu,1 C Scott,1 J Zhao,2 V Plagnol,3 E O’toole,1 D Kelsell1 and Y Yang2 1 Centre 
for Cutaneous Research, Queen Mary University of London, London, United Kingdom, 2 
Department of Dermatology, Peking University First Hospital, Beijing, China and 3 Genetics, 
Evolution & Environment, UCL Genetics Institute, London, United Kingdom
We have identified loss-of-function mutations in the protease inhibitor calpastatin (CAST) gene as 
the genetic cause of an autosomal recessive skin disease characterised by peeling skin, leukony-
chia, acral punctate keratoses, cheilitis and knuckle pads with milia (PLACK syndrome). Patient 
one from a Chinese consanguineous family, presented as an adult with generalised skin peeling 
and a history of superficial acral blistering in childhood, as well as the features above. Patient two 
from a Nepalese family developed acral punctate keratoses and cheilitis age 1 year, acral and limb 
superficial peeling developed age 3 years, as well as leukonychia. Punctate lesions on the dorsum 
of the hands coalesced into knuckle callosities with milia. Exome sequencing showed that both 
patients had homozygous loss-of-function mutations. The Chinese patient had a frameshift muta-
tion (c.607_608insAfs, p.I203Nfs*8) and the Nepalese patient had a nonsense mutation (c.A232T, 
p.K78X). Calpastatin is an endogenous inhibitor of calpain, a calcium-dependent cysteine protease. 
Immunohistochemistry shows CAST is expressed in the suprabasal layers of normal epidermis but 
was reduced in patient skin. Transmission electron microscopy (TEM) revealed widening of inter-
cellular spaces in the upper spinous layer in a patient, suggesting loss of intercellular adhesion. 
A significant increase in apoptotic cells and apoptotic body formation was observed by TUNEL 
and TEM assays in patient skin. In vitro studies utilising siRNA-mediated CAST knockdown (KD), 
confirmed by western blotting, revealed a defect in keratinocyte adhesion. In summary, we describe 
PLACK syndrome caused by loss-of-function mutations in the CAST gene.    
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The Cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling 
N Rajan,1 R Elliott,2 A Smith,2 N Sinclair,1 S Swift,2 C Lord2 and A Ashworth2 1 Newcastle 
University, Newcastle upon Tyne, United Kingdom and 2 The Breakthrough Breast Cancer 
Research Centre, The Institute of Cancer Research, London, United Kingdom
CYLD, an ubiquitin hydrolase, has an expanding repertoire of regulatory roles in cell signalling and 
is dysregulated in a number of cancers. To dissect CYLD function we used a proteomics approach, 
and identified MIB2, an ubiquitin ligase enzyme involved in Notch signalling, as a protein which 
interacts with CYLD. Coexpression of CYLD and MIB2 resulted in stabilisation of MIB2 associated 
with reduced levels of JAG2, a ligand implicated in Notch signalling. Conversely, silencing of 
CYLD using siRNA, resulted in increased JAG2 expression and upregulation of Notch signalling. 
We investigated Notch pathway activity in skin tumours from patients with germline mutations in 
CYLD and found that JAG2 and Notch target genes were upregulated. In particular, RUNX1 protein, 
a Notch target previously associated with leukaemia, was overexpressed in CYLD defective tumour 
cells. Finally, primary cell cultures of CYLD defective tumours demonstrated reduced viability 
when exposed to gamma secretase inhibitors that pharmacologically target Notch signalling. Taken 
together these data suggest crosstalk between the NF-κB and Notch pathways and may indicate 
productive novel therapeutic approaches for patients with CYLD defective tumours. Furthermore, 
the impact of the MIB2-CYLD interaction upon Notch signalling adds to the emerging interactions 
between CYLD and this oncogenic signalling network.    
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Mutations in POGLUT1 and POFUT1 cause Dowling-Degos disease and elucidate a gene-phe-
notype correlation
B Basmanav,1 A Oprisoreanu,1 G Fritz,2 J Wenzel,1 G Lestringant,3 H Thiele,4 S Hanneken,5 
A Bygum6 and R Betz1 1 University of Bonn, Bonn, Germany, 2 University of Freiburg, 
Freiburg, Germany, 3 Tawam University Hospital, Al Ain, United Arab Emirates, 4 University 
of Cologne, Cologne, Germany, 5 University Hospital Düsseldorf, Düsseldorf, Germany and 
6 Odense University Hospital, Odense, Denmark
Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by pro-
gressive reticulate hyperpigmentation. We had previously identified loss-of-function mutations in 
KRT5 in fewer than half of the individuals of our DDD cohort. Recently mutations in POFUT1 were 
reported for DDD. Here we describe the identification of a novel gene for DDD. We perfomed 
exome sequencing on five unrelated individuals with similar DDD phenotypes. Data analysis 
revealed 3 mutations, all of which are in POGLUT1, encoding protein O-glucosyltransferase 1. 
POGLUT1 and POFUT1 are both involved in posttranslational modification of Notch receptors. By 
further screening DDD cases, we identified six additional mutations in POFUT1 and 6 novel muta-
tions in POGLUT1. Immunohistochemistry of skin biopsies showed significantly weaker POGLUT1 
staining in the upper parts of the epidermis compared to healthy controls. Immunofluorescence 
analysis identified a co-localization of the wild type protein with the ER and a notable aggregating 
pattern for the truncated protein. Of interest, a careful analysis of the phenotypes with mutations 
in the different genes - KRT5, POFUT1 and POGLUT1 - revealed a correlation between the gene 
where the mutation is found and the clinical presentation of the disease. Our results emphasize the 
contribution of Notch pathway to disease pathophysiology and the gene-phenotype correlation in 
this disorder which is very beneficial for molecular diagnostic efforts.    
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Deleterious AP1S3 alleles are associated with pustular psoriasis but not plaque psoriasis
N Setta-Kaffetzi,1 SL Spain,1 VM Patel,1 AA Navarini,1 DA Burden,2 CE Griffiths,3 
MA Simpson,1 CH Smith,1 F Capon1 and JN Barker1 1 King’s College London, London, United 
Kingdom, 2 Department of Dermatology, University of Glasgow, Glasgow, United Kingdom 
and 3 Department of Dermatology, University of Manchester, Manchester, United Kingdom
The pathogenesis of pustular psoriasis (PP) remains poorly understood, as mutations of the IL36RN 
gene (the only known PP locus) only account for a minority of cases. Here, we undertook whole-ex-
ome sequencing in 9 unrelated patients (all suffering from localised disease), with a view to uncover-
ing further genetic determinants for PP. We found that 4 individuals carried a recurrent heterozygous 
allele (p.Arg33Trp) of the AP1S3 gene, which encodes a protein involved in intra-cellular vesicular 
transport. To validate our genetic findings, we screened AP1S3 coding exons in 119 subjects 
with localised (n=114) or generalised (n=5) disease. We detected the p.Arg33Trp substitution in 5 
affected individuals and uncovered a p.Phe4Cys change in a further 6 cases. In-depth bioinformatics 
and structural analyses indicated that both variants had clear pathogenic potential. Moreover, the 
frequency of the damaging alleles was significantly higher in the patient cohort than in the general 
population, as demonstrated by the analysis of 1,695 unrelated controls (p=2.5x10-7). Since 7 of the 
14 patients bearing mutations presented with concomitant psoriasis vulgaris (PV), we next sought 
to determine whether AP1S3 variants also contribute to PV susceptibility. The analysis of a publicly 
available ImmunoChip dataset (10,588 psoriasis cases vs. 22,806 controls) showed no evidence 
of association between AP1S3 alleles and PV (p>0.1). Moreover, the interrogation of preliminary 
HumanExome chip data did not reveal any enrichment of low frequency AP1S3 alleles among PS 
cases. Taken together, these findings identify AP1S3 mutations as a new genetic determinant for 
pustular psoriasis and support the notion of a distinct genetic basis for this condition.    
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FERMT1 promoter mutations in patients with Kindler syndrome
C Has,2 N Chmel,2 L Levati,1 M Pigors,2 L Bruckner-Tuderman,2 G Zambruno1 and D Castiglia1 
1 Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell’Immacolata, Rome, 
Italy and 2 Dermatology, Medical Center - University of Freiburg, Freiburg, Germany
Mutations in the FERMT1 gene, encoding the focal adhesion protein kindlin-1 underlie the KS, an 
autosomal recessive skin disorder with a phenotype comprising skin blistering, photosensitivity, 
progressive poikiloderma with extensive skin atrophy, and propensity to skin cancer. FERMT1 muta-
tional spectrum comprises gross genomic deletions, splice site, nonsense and frameshift mutations, 
which are scattered over the coding region spanning exon 2 to 15. A single genomic deletion over 
the putative FERMT1 promoter sequence and the first noncoding exon has been recently described. 
We now report three additional KS families with mutations affecting the promoter region of FERMT1. 
Two of these mutations are large deletions (~38.0 and 1.9 kb in size) and one is a single nucleotide 
variant (c.-20A>G) within the 5’UTR. Each mutation resulted in loss of gene expression in the skin 
or in cultured keratinocytes from the patients. Reporter assays demonstrated the functional relevance 
of the genomic regions deleted in our patients for FERMT1 gene transcription and proved the causal 
role of the c.-20A>G variant in abrogating transcriptional activity.    
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Genome-wide association study identifies three novel susceptibility loci for severe acne 
vulgaris 
AA Navarini,1 MA Simpson,1 ME Weale,1 A Layton,2 JJ Voegel,4 T Group,1 T Spector,3 
C Smith,6 RC Trembath5 and JN Barker1 1 Division of Genetics and Molecular Medicine, 
London, United Kingdom, 2 Department of Dermatology, Harrogate and District Foundation 
Trust, Harrogate, United Kingdom, 3 Twin Research and Genetic Epidemiology Unit, Division 
of Genetics and Molecular Medicine, King’s College, London, United Kingdom, 4 Galderma 
SA, Sophia-Antipolis, France, 5 Barts and the London School of Medicine and Dentistry, 
Queen Mary University of London, London, United Kingdom and 6 St John’s Institute of 
Dermatology, Guy’s and St.Thomas’ NHS Foundation Trust, London, United Kingdom
Acne vulgaris (acne) is a common complex inflammatory skin disease associated with irreversible 
scarring. The pathophysiology is centered on the pilosebaceus unit but primary events remain poorly 
understood. Twin studies show high heritability of 80%, indicating a genetic basis for acne. How-
ever, efforts to characterize the genomic risk loci for acne have been limited. Using a national net-
work of dermatologists within the United Kingdom, we recruited subjects with severe acne. Initially, 
a genome-wide association analysis was performed in cases (n = 1,893, 88% isotretinoin-treated, 
28% nodulocystic) and unselected controls (n = 5,132). In a second stage, we genotyped 350 puta-
tive associated SNPs in a further 2,063 cases and 1,970 controls with no past or present history of 
acne. Three genome-wide significant associations were identified: 11q13.1 (rs478304: Pcombined = 
3.23 x 10-11, odds ratio (OR) = 1.20), 5q11.2 (rs38055, Pcombined = 4.58 x 10-9, OR = 1.17) and 
1q41 (rs1159268: Pcombined = 4.08 x 10-8, OR = 1.17). All three loci contain genes linked to the 
TGFβ cell signaling pathway, namely OVOL1, FST and TGFB2. Transcripts of OVOL1 (Padjusted = 
4 x 10-2) and TFGB2 (Padjusted = 6 x 10-4) were reduced in biopsies of acne lesions compared to 
uninvolved skin. We could not confirm two association signals close to genes involved in leukocyte 
adhesion (SELL) and DNA damage response (DDB2) published in a recent Han Chinese GWAS. 
Collectively, these data support a key role for dysregulation of TGFβ mediated signaling in acne 
and motivate more in-depth functional studies on the role of TGFβ in acne.    
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Hidradenitis suppurativa: Haploinsufficiency of the γ-secretase components NCSTN and 
PSENEN does not affect γ-secretase enzyme activity in vitro
AE Pink,1 D Dafou,2 N Desai,1 O Holmes,3 C Smith,2 P Mortimer,4 MA Simpson,2 
RC Trembath2 and JN Barker2 1 St. John’s Institute of Dermatology, London, United Kingdom, 
2 King’s College London, London, United Kingdom, 3 Harvard Medical School, Boston, MA 
and 4 St. George’s Medical School, London, United Kingdom
Hidradenitis suppurativa (HS) is a debilitating inflammatory dermatosis that can be inherited in 
an autosomal dominant manner. Heterozygous mutations have been reported in the γ-secretase 
genes NCSTN, PSENEN and PSEN1. The aim of this study was to assess the location of γ-secretase 
components in the skin and ascertain the molecular mechanisms by which two previously reported 
mutations (NCSTN c.1125+1 G>A, PSENEN c.66_67insG) result in HS. Immunohistochemical 
analysis of axillary skin from unaffected volunteers and mutation-positive patients revealed co-lo-
calisation of NCSTN and PSENEN in the epidermis, hair follicle, sebaceous gland, apocrine gland, 
fibroblasts and inflammatory infiltrates. NCSTN c.1125+1 G>A resulted in aberrant splicing and 
skipping of NCSTN exon 9 (predicted protein p.Glu333_Gln367del). PSENEN c.66_67insG was 
predicted to result in a frameshift and an altered protein product (p.Phe23ValfsX98). NCSTN and 
PSENEN mRNA expression was reduced in primary dermal fibroblasts harvested from the respec-
tive mutation-positive patients vs. healthy volunteers. NCSTN and PEN-2 (encoded by PSENEN) 
protein expression was correspondingly reduced in respective mutant dermal fibroblasts vs. wild 
type controls. Enzyme activity assays were performed using solubilised cell membrane protein 
derived from primary human fibroblasts in vitro. There was no significant difference in complex 
number, maturity or endopeptidase or carboxypeptidase-like enzyme activity in samples harvested 
from mutation-positive patients vs. unaffected volunteers. Overall, these studies revealed that both 
NCSTN and PSENEN are expressed and co-localise in the skin and that haploinsufficiency of these 
γ-secretase components underlies some cases of HS. This conferred no demonstrable affect on 
γ-secretase enzyme activity in vitro under the conditions studied.    
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Impaired TGFβ signalling and differentiation in Linear morphea fibroblasts which down-
regulate SOSTDC1
SJ Brown,1 L Weibel,2 B Way,1 J Harper1 and R O’Shaughnessy1 1 Immunobiology and 
Dermatology, UCL Institute of Child Health, London, United Kingdom and 2 Dermatology, 
University of Zurich, Zurich, Switzerland
Linear morphea(LM) is a skin restricted fibrotic disorder with unknown cause. The disease bears 
similarity to processes which occur during wound healing, where a TGFβ-rich environment is 
thought to encourage fibroblast collagen production, activation and differentiation. In this study, 
fibroblasts were isolated from lesional skin and compared with normal site-matched fibroblasts. 
Cellular phenotype, transcriptome, and TGFβ signalling kinetics were examined. LM fibroblasts 
showed altered proliferation, migration and contact inhibition compared to non-lesional fibroblasts. 
Transcriptome analysis showed changes in TGFβ responsive transcripts, and downregulation of 
SOSTDC1, a key regulator of TGFβ, Wnt and BMP signalling. A study of 8 lesional skin sections 
found 50% with SOSTDC1 downregulation (n=8), which was consistent across different sites in 
the same patient. Analysis of systemic sclerosis lesions showed 40% down-regulated SOSTDC1 
(n=5). Basal levels of SMAD phosphorylation were increased in LM fibroblasts, even when serum 
starved, which paradoxically reduced further induction in response to TGF-β1 stimulus. Consistent 
with the observed TGFβ dysfunction, ACTA expression, a marker of myofibroblast differentiation, 
was altered in LM fibroblasts. SOSTDC1 knockdown increased migration, and altered basal SMAD 
phosphorylation and response to TGF-β1, in a similar fashion to human LM fibroblasts. In conclu-
sion, Linear morphea fibroblasts down-regulate SOSTDC1, which alters cellular migration, contact 
inhibition and TGFβ signalling. Basal SMAD phosphorylation was increased and LM fibroblasts 
show altered myofibroblast differentiation. SOSTDC1 downregulation is a common feature of linear 
morphea disease, suggesting future therapeutic possibilities for the treatment of Scleroderma such 
as re-introduction of SOSTDC1, or unaffected fibroblasts, to an affected site.    
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Skin-specific transgenic Kallikrein 5 mice reproduce major cutaneous and systemic hallmarks 
of Netherton syndrome : a viable model for therapeutic development 
L Furio, S de Veer, M Jaillet, A Briot, A Robin, C Deraison and A Hovnanian Imagine Institute 
of Genetic Diseases, Laboratory of genetic skin diseases, INSERM UMR1163, Paris, France
Netherton syndrome (NS) is a severe genetic skin disease in which absence of LEKTI, a key protease 
inhibitor causes congenital exfoliative erythroderma, eczematous-like lesions and atopic manifes-
tations. Several proteases are overactive in NS, including kallikrein-related peptidase (KLK)5, KLK7 
and elastase-2 which are suggested to be part of a proteolytic cascade initiated by KLK5. To address 
the roles of KLK5 in NS, we have generated a new transgenic murine model expressing human 
KLK5 in the granular layer of the epidermis (Tg-KLK5). Transgene expression resulted in increased 
proteolytic activity attributable to KLK5 and its downstream targets KLK7, KLK14 and ELA2. Tg-KLK5 
mice developed an exfoliative erythroderma with scaling, growth delay and hair abnormalities. 
The skin barrier was defective and the stratum corneum was detached via desmosomal cleavage. 
Importantly, Tg-KLK5 mice displayed cutaneous and systemic hallmarks of severe inflammation and 
allergy with pruritus. Overtime, persistent scratching led to alopecic, erosive and crusty skin lesions 
with lymph nodes hyperplasia. The skin showed enhanced expression of inflammatory cytokines and 
chemokines, infiltration of immune cells, and markers of Th2/Th17/Th22 T cell responses. Moreover, 
serum IgE and Tslp levels were elevated. Our study identifies KLK5 as an important contributor to 
the NS proteolytic cascade. Tg-KLK5 mice help dissecting the complex pathophysiology of NS and 
and provide a new and viable model for the evaluation of future targeted therapies for NS or related 
diseases such as atopic dermatitis.    
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Functional human epidermal equivalent derived from induced pluripotent stem cells as a 
model to study genetic correction in Epidermolysis bullosa
A Petrova,1 W Di,1 D Ilic,2 T Mauro,3 JA McGrath,4 A Thrasher1 and W Qasim1 1 Institute of 
Child Health, University College London, London, United Kingdom, 2 Assisted Conception 
Unit, King’s College London, London, United Kingdom, 3 Dermatology Research Unit, 
Veterans Affairs Medical Center, San Francisco, CA and 4 St. John’s Institute of Dermatology, 
King’s College London, London, United Kingdom
Epidermolysis bullosa (EB) constitutes a group of genetic diseases that result in skin fragility, debili-
tating blistering and scarring. Recessive dystrophic epidermolysis bullosa (RDEB) is one of the most 
aggressive forms of EB, caused by absence of normal collagen VII (COL7A1) gene. While significant 
progress is being made in the field of molecular therapies for RDEB, including gene, protein and 
cell therapy, a suitable source for efficient replacement of diseased keratinocytes is still lacking. 
Recent development of induced pluripotent stem cells (iPSCs) that are generated from the somatic 
cells of individual patients, possess unlimited proliferation potential and are easily amendable for 
the correction of gene mutation by homologus recombination. Here we demonstrate the genera-
tion of the physiologically-relevant model of human epidermis from iPSCs. We have developed a 
4 step differentiation protocol to obtain a pure population of iPSC-derived keratinocytes, whose 
transcriptome corresponds to the gene signature of normal primary human keratinocytes (NHK). 
Furthermore, following a sequential high-to-low humidity environment in an air-liquid interface 
culture of iPSC-derived keratinocytes, we were able to generate a functional human epidermal 
equivalent (HEE) with all cellular strata of the human epidermis and skin barrier with properties 
similar to normal skin. Such HEE generated from genetically-corrected RDEB-iPSC will be an invalu-
able tool not only for dissection of molecular mechanisms leading to epidermal barrier defects but 
will also be instrumental for drug development and screening. Our future goal is to develop a next 
generation skin stem cell therapeutic for RDEB.    
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Optimization of liposomal carriers for RNAi-based topical therapies for skin diseases
E Desmet, M Van Gele, S Bracke and JL Lambert Dermatology, Ghent University Hospital, 
Ghent, Belgium
Recently, our group developed ultradeformable SECosomes (Surfactant-Ethanol-Cholesterol contain-
ing liposomes) which enabled siRNA delivery in cultured primary skin cells, and human (psoriatic) 
ex vivo skin. Here, we aim to optimize their transfection and penetration efficiency for their use as 
topical delivery system for therapeutic RNAi molecules in the treatment of psoriasis and other skin 
diseases. By altering the ‘SEC’ formulation, six new liposomes were developed and analyzed as 
potential RNAi delivery vesicle by examining their size, surface charge, morphology, and encap-
sulation efficiency. The in vitro transfection efficiency of the different liposomes was also tested in 
psoriasis-induced keratinocytes. Changing the helper lipid or surfactant in the ‘SEC’ formulation or 
lowering the ethanol percentage (SEC20) did not result however in major differences. Interestingly, 
liposomes containing two helper lipids (‘DDC’) produced favorable vesicles, indicated by their size, 
homogeneity, morphology, encapsulation efficiency (> 90%) and in vitro transfection efficiency. 
The three best formulations were subjected to ex vivo penetration studies in Franz diffusion cells 
and excised normal and psoriasis human skin. Confocal imaging indicated that in normal human 
skin the SEC and SEC20 remained restricted to the SC, whereas the DDC liposomes penetrated 
into the different epidermal layers, without transdermal delivery. As the skin barrier is disrupted 
in psoriasis, the SEC and SEC20 were able to penetrate throughout the epidermis and rete ridges, 
comparable to the DDC penetration in psoriatic skin. Currently, DDC complexes containing siRNA 
against hBD-2 are applied topically to ex vivo psoriatic skin to investigate the therapeutic effect 
of hBD-2 knockdown. In conclusion, we identified a new promising liposome, ‘DDC’, capable of 
delivering RNAi therapeutics to psoriatic and normal human skin, without targeting the dermis and/
or circulatory system. These liposomes could be used as topical carrier system for psoriasis as well 
as for other skin diseases characterized by an intact skin barrier.    
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3D-skin models for protein substitution in autosomal recessive congenital ichthyosis
R Plank,1 M Rauch,1 R Casper,2 K Obst,3 S Küchler,3 K Eckl1 and H Hennies1 1 Div. of 
Human Genetics & Dept. of Dermatology, Innsbruck Medical University, Center for 
Dermatogenetics, Innsbruck, Austria, 2 Cologne Center for Genomics, Univ. of Cologne, 
Center for Dermatogenetics, Cologne, Germany and 3 Institute of Pharmacy, Freie Universität 
Berlin, Berlin, Germany
Here we describe an approach towards personalized protein replacement therapy in autosomal 
recessive congenital ichthyosis (ARCI). TGase1, 12R-LOX and eLOX3 are crucial enzymes acting in 
the same pathway important for differentiation of the skin. Mutations in the respective genes lead to 
an ARCI phenotype with hyperkeratosis, scaling, erythema and impaired skin barrier function. This 
project focusses on a causative, personalized treatment for ARCI patients substituting the missing 
enzyme instead of symptomatic treatment, which is the standard management up to now. Therefore 
we have cloned the genes TGM1, ALOX12B and ALOXE3 into GFP- and His-tagged plasmid vectors 
respectively. FACS-analyses, fluorescence microscopy and western blot have been used to assess 
mammalian expression systems under various conditions with the GFP-tagged vectors. In a second 
step His-tagged vectors were used in the optimized protein expression protocol for a larger-scale 
setup. Obtained cell lysates were then purified by nickel and cobalt NTA beads and TGase1 was 
tested via ELISA for its specific activity. In parallel we have constructed ARCI 3D-skin models 
using gene knockdown with siRNA and characterized them regarding epidermal morphology and 
differentiation by real time-PCR and immunohistochemistry staining. The models are now being 
used for testing advanced topical drug delivery systems like microneedles and hyaluronic acid. We 
expect to insert and replace the missing enzymes such as TGase1, 12R-LOX and eLOX3 in order to 
restore the regular keratinocyte differentiation and epidermal barrier function. Once the principle 
is established we will be able to adapt this type of therapy also to other known genes involved in 
the development of congenital ichthyosis.    
Genetic Disease, Gene Expression and Gene Therapy | ABSTRACTS
www.jidonline.org   S55
313
A case of pseudoxanthoma elasticum like disorder with multiple coagulation deficiency
K Yoshimi, Y Okubo, S Ikehara, Y Koike, Y Kuwatsuka and A Utani Dermatology, Nagasaki 
University Hospital, Nagasaki, Japan
Pseudoxanthoma elasticum like disorder with multiple coagulation deficiency (tentatively named 
GGCX syndrome ) is known to be caused by GGCX (gamma-glutamyl carboxylase) gene mutation. 
GGCX is an enzyme that carboxylates glutamate residue in a group of proteins including anti-calcifi-
cation molecules (matrix gla protein(MGP), alpha-fetuin, etc), and vitamine K dependent coagulation 
factors. We report a 55 years old Japanese male with GGCX syndrome shows pseudoxanthoma 
(PXE)-like phenotype such as cutis laxa, calcification of elastic fibers in the dermis, peripapillary 
atrophy of the retina, and coagulation deficiency. Furthermore he has been suffered from dysarthria 
and motor ataxia suspect of spinocerebellar degeneration as unreported phenotype. We found 
homozygous deletion of T within C-terminal end. It produces frameshift and yields 77 amino 
acid larger molecule of GGCX. Abnormal GGCX molecule located in rER in patient fibroblasts, 
which was similar pattern in normal fibroblasts. However one of GGCX substrate MGP was under 
carboxylated demonstrated by western blotting using carboxylation dependent antibody to MGP. 
These data suggest that this mutation induced loss of function of GGCX resulted in elastic fiber 
calcification as well as coagulation deficiency. The reason why he had symptoms due to possible 
spinocerebellar degeneration remains to be elucidated.    
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A common atopy-associated variant in the Th2 cytokine locus control region impacts tran-
scriptional regulation and alters SMAD3 and SP1 binding 
A Kretschmer,1 H Prokisch,2 S Eyerich,3 S Hauck,4 A Peters,1 J Adamski,5 E Reischl1 and 
S Weidinger6 1 Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, 
Neuherberg, Germany, 2 Institute of Human Genetics, Helmholtz Zentrum München, 
Neuherberg, Germany, 3 Zentrum Allergie und Umwelt (ZAUM), Munich, Germany, 4 
Research Unit Protein Science, Helmholtz Zentrum München, Neuherberg, Germany, 5 
Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, 
Neuherberg, Germany and 6 Department of Dermatology, Venereology and Allergy, 
University Hospital Schleswig-Holstein, Kiel, Germany
Type 2 immune responses play major pathogenic roles in atopic diseases. They are directed by 
Th2 cells and characterized by the signature cytokines IL4, IL5 and IL13. Single nucleotide poly-
morphisms in the human Th2 cytokine locus and variants in an intronic region of the DNA-repair 
gene RAD50, including the RAD50 DNase1 hypersensitive site 7 (RHS7), have been associated with 
atopic traits in genome-wide association studies. This study aimed to characterize the functional 
impact of the common atopy associated polymorphism rs2240032 located in the human RHS7 
on cis-regulatory activity and on differentially binding transcription factors (TF). TF binding was 
analyzed by electrophoretic mobility shift assays with Jurkat T cell nuclear extracts. TF identification 
was performed by mass spectrometry. Reporter vector constructs carrying the major or minor allele 
of rs2240032 were tested for regulating transcription activity in Jurkat and HeLa cells. Allele-spe-
cific binding of SMAD3, SP1 and additional putative protein complex partners was identified 
at rs2240032. The atopy risk allele exhibited decreased SMAD3 and SP1 binding and showed 
significantly enhanced promoter activity compared to the non-risk allele in Jurkat cells. rs2240032 
is located in an RHS7 subunit which itself encompasses repressor activity and might be important 
for the fine-tuning of transcription regulation within this region. The human RHS7 contributes to 
the regulation of gene transcription, and the atopy-associated polymorphism rs2240032 impacts 
transcriptional activity and TF binding.    
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A composite enhancer regulates p63 gene expression in epidermal morphogenesis and in 
keratinocyte differentiation by multiple mechanisms 
D Antonini,2 A Sirico2 and C Missero1 1 Department of Biology, University of Naples Federico 
II and CEINGE, Napoli, Italy and 2 CEINGE – Center for Genetic Engineering, Napoli, Italy
p63, a master regulator of keratinocyte gene expression, is the first epidermal marker to be expressed 
in the surface ectoderm during embryonic development, and becomes progressively confined to the 
basal proliferative layer of the developing epidermis. The mechanisms that mediate p63 expression 
in the developing skin and in epidermal differentiation are still poorly understood. Here we report 
the identification of a novel genomic regulatory element that, combined with the previously char-
acterized C40 element, constitutes a keratinocyte-specific long-range enhancer (p63LRE). Consistent 
with their function, both elements are in an open and active chromatin state in keratinocytes and 
in embryonic epidermis. The genomic region encompassing the two elements drives strong and 
basal cell-specific expression in mouse embryonic and newborn epidermis, with a p63-dependent 
mechanism as determined in a p63-null background. While p63 sustains its own transcription 
through the p63LRE element, a search for other transcriptional regulators revealed that a subset of 
transcription factors involved in commitment to differentiation acts as repressor of p63 transcription 
in differentiated keratinocytes.    
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A newly identified missense mutation of the EDA1 gene in a Hungarian patient with Christ–
Siemens–Touraine syndrome
ÁGNES Kinyó,2 P Vályi,3 K Farkas,2 N Nagy,1 B Gergely,2 K Tripolszki,1 D Török,1 Z Bata-
Csorgo,2 L Kemény2 and M Széll1 1 Department of Medical Genetics, University of Szeged, 
Szeged, Hungary, 2 Department of Dermatology and Allergology, University of Szeged, 
Szeged, Hungary and 3 Department of Periodontology, University of Szeged, Szeged, 
Hungary
Christ–Siemens–Touraine syndrome (CST; OMIM 305100) belongs to the group of ectodermal 
dysplasias and is characterized by the development of sparse hair, abnormal or missing teeth and 
sweating deficiency. CST is the consequence of mutations located in the ectodysplasin A (EDA1) 
gene. We have identified a 35-year-old Hungarian man with characteristic dysmorphic facial fea-
tures, sparse hair, reduced sweating and missing teeth. Direct sequencing of the coding regions 
revealed a novel missense mutation in the eighth exon (c.971T/A, p.Val324Glu). The affected patient 
carries the mutation in a hemizygous form. Previous studies reported the association of missense 
mutations with non-syndromic tooth agenesis. However, the reported hemizygous patient exhibits 
hypodontia as well as hypotrichosis and reduced sweating. His daughter, an obligate heterozygous 
carrier of the identified missense mutation, exhibits only mild teeth abnormalities. As the novel 
missense mutation is located within the tumor necrosis factor (TNF) domain of the ectodysplasin 
protein, we hypothesize that this genetic variant affects the ectodysplasin/NFκB signaling pathway.   
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A novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome pre-
senting with two distinct clinical features: keratinocytic epidermal nevi and sebaceous nevi
S Igawa,1 M Honma,1 M Minami-Hori,1 E Tsuchida,2 H Iizuka1 and A Ishida-Yamamoto1 1 
Dermatology, Asahikawa Medical University, Asahikawa, Japan and 2 Pediatrics, Asahikawa 
Medical University, Asahikawa, Japan
Epidermal nevus syndrome (ENS) refers to a heterogeneous group of congenital disorders char-
acterized by the presence of epidermal nevi associated with systemic involvement. Keratinocytic 
epidermal nevus syndrome and nevus sebaceous/Schimmelpenning syndrome are included in this 
group. Recently, keratinocytic epidermal nevus (KEN) and sebaceous nevus (SN) were found to be 
caused by postzygotic mutations in several genes related to cell proliferation, among which are 
HRAS and KRAS. Interestingly, the same point mutation was reported in KEN and SN. An intriguing 
question is whether or not KEN and SN are the same disease. We report a case of a two-year-old 
Japanese girl with two types of nevi on the left side of her body following Blaschko lines present 
since birth: yellowish plaques suggesting SN on the head and face, and dark brownish verrucous 
plaques suggesting KEN on the trunk and lower extremity. Detailed examination revealed delayed 
eruption of the left teeth and a left cerebral arachnoid cyst. Mutation analysis showed a KRAS 
c.34G>T p.G12C point mutation in genomic DNA derived from her lesional epidermis but not in 
her nonlesional epidermis or peripheral blood leukocytes. This KRAS mutation has been reported 
in various carcinomas and sarcomas, but to the best of our knowledge, it has never been reported 
in KEN, SN or ENS. Keratinocytic epidermal nevus syndrome and nevus sebaceous syndrome have 
been considered to be different diseases because of differences in clinical features and frequency 
of systemic involvements. However, our case strongly suggests that both KEN and SN, which are 
within an identical disease spectrum can be induced by the same KRAS mutation. Clinical feature 
variation may depend on the developmental stages at which the postzygotic mutation occurred 
and/or anatomical characteristics of the affected areas.    
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A weighted polygenic risk score using 14 known susceptibility variants to estimate risk and 
age onset of type-I psoriasis 
X Yin,1 H Cheng,1 NE Wineinger,2 NJ Schork3 and X Zhang1 1 Anhui Medical University, 
Hefei, China, 2 The Scripps Research Institute, La Jolla, CA and 3 The Craig Venter Institute, 
La Jolla, CA
The purpose is to establish genetic prediction models and evaluate its discriminatory ability in 
psoriasis in Han Chinese population. We built the genetic prediction models through weighted 
polygenic risk score(PRS) and confidence interval-based modeling using 14 susceptibility variants 
in 7,347 samples. The predictive ability was evaluated by receiver operating characteristic anal-
ysis. The probability of psoriasis age onset was estimated using Cox proportional hazard models. 
We found the risk of psoriasis among individuals in the top quartile of the PRS was significantly 
larger than those in the lowest quartile of PRS (OR = 28.20, 95%CI: 22.95 - 34.95, P < 2.0×10-16). 
We also observed statistically significant associations between the PRS, family history and early 
age onset of psoriasis. We also built a predictive model with all 14 known susceptibility variants 
and alcohol consumption, which achieved an area under the curve statistic of ~ 0.88. Our study 
suggests that 14 psoriasis known susceptibility loci have the discriminating potential, as is also 
associated with family history and age of onset. This is the genetic predictive model in psoriasis 
with the largest accuracy to date.    
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Alteration of epidermal ceramides in a patient with Dorfman-Chanarin syndrome and a 
15,935 bp deletion of ABHD5 
B Roussel,2 C Prost-Squarcioni,1 F Nery,3 L Laroche,4 P Schischmanoff5 and F Caux2 
1 Histology, SMBH, Bobigny, France, 2 INSERM U1125, SMBH, Bobigny, France, 3 
Hepatology, Hopital Beaujon, Clichy, France, 4 Dermatology, Avicenne Hospital, Bobigny, 
France and 5 Biochemistry, Avicenne Hospital, Bobigny, France
ABHD5 is an activator of the ATGL lipase. ABHD5 mutations induce ichthyosiform erythroderma 
and an intracellular accumulation of lipid droplets known as Dorfman-Chanarin syndrome (DCS). 
We report an unusual large deletion of ABHD5 in a new patient with DCS and studied ceramides in 
his skin. A Moroccan with ichthyosiform erythroderma and lipid droplet in leukocytes was studied. 
ABHD5 gene and transcript were analysed. Skin of the patient was examined by electron microscopy 
(EM) and immunofluorescence (IF) using monoclonal antibodies against ABHD5 and ceramides. 
Analysis of patient ABHD5 mRNA demonstrated no amplicon by RT-PCR and RT-qPCR. PCR using 
genomic DNA revealed no amplicons for exons 1 and 2. Using regularly distributed primer pairs 
from intron 2 to -40,391 bp we detected a large deletion of 15,935 bp and an insertion of 46 bp 
between the borders. Bioinformatic analysis of the breakpoints revealed presence of LINE-1PA4 
and Alu-Sb1 sequences; the 46 bp insertion had 98% of homology with an Alu-Sb1 sequence. EM 
analysis of skin showed cytoplasmic vacuoles in keratinocytes, melanocytes and fibroblasts. ABHD5 
protein was absent in the sebaceous gland in the patient’s skin but present in control skin by IF. 
Ceramides were detected in stratum corneum (SC) of normal skin but lacking in the patient’s skin 
by IF. To date, this deletion is the largest described in the literature among 32 distinct mutations and 
could be related to a non homologous recombination between LINE-1 and Alu repeats. This deletion 
results in the total absence of ABHD5 mRNA and protein, leading to a lack of some ceramides in 
the SC observed by IF. This is in accordance with recent data using thin-layer chromatography and 
mass spectrometry imaging. In conclusion we report a new DCS patient with an original deletion 
of ABHD5 and changes of epidermal ceramides which could be involved in the pathophysiology 
of this type of ichthyosis.    
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CARD14 Mutations in Familial and Sporadic Pityriasis Rubra Pilaris: Activation of NF-kappaB
Q Li,1 H Chung,1 J Andrews,1 N Ross,1 H Sabaawy,2 E Sprecher,3 H Hakonarson4 and J Uitto1 
1 Jefferson Medical College, Philadelphia, PA, 2 Rutgers-Cancer Institute, New Brunswick, NJ, 
3 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel and 4 Children’s Hospital of Philadelphia, 
Philadelphia, PA
Pityriasis rubra pilaris (PRP), a papulo-squamous inflammatory skin disorder, is in most cases 
sporadic, but a familial form, <6% of cases, with autosomal dominant inheritance with partial 
penetrance has been reported. We recently demonstrated that patients with familial PRP harbor 
gain-of-function mutations in the CARD14 gene, an activator of NF-κB. This study investigates 
whether mutations in this gene also underlie cases of sporadic PRP. DNA from 48 confirmed PRP 
patients with no family history was used for amplification of exons 3 and 4 of CARD14 which 
harbor mutations in familial PRP. The remaining 18 exons were analyzed in a subset of 20 patients 
with a definitive diagnosis of PRP, also confirmed by clinical and histopathologic features. Among 
the 16 sequence variants detected, 3 potentially pathogenic mutations together with the mutations 
identified in familial PRP, were analyzed on the activation of NF-κB. In vitro assay was performed 
in transgenic HeLa cells constitutively expressing a luciferase reporter under a NF-κB responsive 
element. This approach indicated that all four CARD14 mutations in familial PRP and one CARD14 
mutation in sporadic PRP activated NF-κB. Thus, while NF-κB activation may be a common mech-
anism in familial PRP, CARD14 mutations are present, yet rare, in sporadic cases. To identify the 
genetic basis for sporadic PRP, we selected four cases, with characteristic clinical presentation and 
histopathology but without identifiable CARD14 mutations, for whole exome sequencing. Over 
4000 sequence variants were called based on the hg19 reference genome using the Annovar soft-
ware tool. Among them, 15 sequence variants have allele frequencies <5% in the 1000 Genomes 
Project and in the NHLBI Exome Sequencing Project. Of these, three are nonsynonymous in 3 
different genes, suggesting a role in the pathogenesis of PRP.    
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Characterization of a novel mutation in Peeling skin disease and insights into the inflammatory 
component of the disease 
F Valentin,1 N Jonca,4 E Liebau,2 T Tarinski,1 H Traupe,1 O Angün,3 P Terheyden3 and 
V Oji1 1 Department of Dermatology, Münster, Germany, 2 University of Münster, Münster, 
Germany, 3 Department of Dermatology, Lübeck, Germany and 4 CR2INSERM Toulouse, 
Toulouse, France
Generalised peeling skin disease (PSD, MIM 270300) is a rare autosomal-recessive form of con-
genital ichthyosis. The disease manifests shortly after birth with pronounced erythroderma. In addi-
tion, affected individuals develop a generalised, inflammatory, pruritic patchy peeling of the skin. 
Recently the loss of corneodesmosin (Cdsn) in the superficial layers of the epidermis, caused by 
nonsense mutations of the CDSN gene, was identified to be responsible for the disease. In the present 
study we analysed the so far unpublished mutation I.345SfsX121 in a compound heterozygous 
patient suffering from PSD, whose second mutation was p.Lys59X. CDSN gene expression was 
analysed using qRT-PCR and shows decreased expression levels. Immunohistochemistry revealed 
a residual Cdsn expression, western blot analysis suggested presence of a truncated protein in the 
epidermis. To get further insights into the pathophysiology of the epidermis in PSD we examined 
expression levels of caspase-1 (CASP1) and IL18, which showed elevated expression levels in 
keratinocytes. Our results suggest nonsense–mediated mRNA decay of a truncated Cdsn form. This 
CDSN down-regulation is contrary to another previously characterized mutation which showed 
elevated expression levels in PSD. The increased expression of CASP1 and IL18 in Cdsn deficiency 
may be a key feature of the inflammatory component, which correlates with the clinical symptoms 
of the patients, who suffer from severe pruritus and atopic manifestations.    
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Comparative transcriptome analysis in rosacea subtypes display features of the same disease 
complex without conclusive consecutive evolution
M Steinhoff,1 M Sulk,2 V Schwab,3 P Nowak,3 J Buddenkotte,3 F Cevikbas,2 C Kempkes,2 
J Aubert,4 JJ Voegel4 and T Buhl5 1 Charles Institute for Translational Dermatology, UCD, 
Dublin, Ireland, 2 Dermatology, UCSF, San Francisco, CA, 3 Dermatology, UKM, Münster, 
Germany, 4 Molecular Dermatology, Galderma R&D, Sophia Antipolis, France and 5 
Dermatology, UMG, Göttingen, Germany
Rosacea is a chronic inflammatory skin disease of poorly understood origin. Based on its char-
acteristic clinical features (flushing, erythema, burning, chronic inflammation, fibrosis, glandular 
hyperplasia) and trigger factors, a complex pathobiology involving dysregulation in the immune, 
vascular, and nervous system can be anticipated. To identify the distinct and commonly dysregulated 
genes in the different rosacea subtypes, we analyzed whole-transcriptome expression profiles in 
patients with erythematotelangiectatic rosacea (ETR), papulopustular rosacea (PPR), phymatous 
rosacea (PhR) and compared with non-lesional skin of same patient or healthy volunteers. In ETR, 
dysregulated lipid metabolism and activation of the innate immune system represent the most 
dysfunctional gene groups, whereas PPR patients display predominantly a complex activation of 
multiple pathways of innate and adaptive immunity. PhR patients revealed many similarities with 
PPR gene analyses, but additional genes involved in tissue remodeling in association to inflammation 
were significantly elevated. In contrast, epidermal growth factor and Wnt signaling family members 
show diminished expression profiles. Strikingly, comparison of ETR, PPR, and PhR with non-lesional 
skin or healthy volunteers reveals dysregulation within the same identical gene sets in 49-72% of all 
altered genes, depending on rosacea subtype. Thus, the three rosacea subtypes are closely related 
manifestations of the same disease complex; however, conclusions drawn from our data do not 
support a direct linear evolution of the disease (e.g., beginning with ETR, development to PPR, and 
finally occurrence of PhR). This study is the most comprehensive transcriptome analysis of rosacea 
pathophysiology to date and highlights several new candidates for possible therapeutic interventions.   
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Correction of type VII collagen in dystrophic epidermolysis bullosa by novel trans-splicing 
molecules
P Peking, E Mayr, U Koller, S Hainzl, T Kocher, JW Bauer and EM Murauer Department 
of Dermatology, Division of Experimental Dermatology and EB House Austria, Paracelsus 
Medical University, Salzburg, Austria
Premature termination codons in the COL7A1 gene lead to absence of type VII collagen and 
anchoring fibrils in the dermal-epidermal junction (DEJ) of the skin, causing severe autosomal 
recessive dystrophic epidermolysis bullosa (RDEB). The phenotype of this skin disease reveals 
severe blistering after mechanic trauma, that significantly affects the quality of life. As a causative 
therapy approach, we use spliceosome-mediated RNA trans-splicing (SMaRT), where artificially 
designed RNA trans-splicing molecules (RTMs) specifically replace distinct exons during the natural 
occurring splicing process. In this study we examine the functionality of the trans-splicing technology 
using a murine RDEB model. To correct a murine Col7a1 hypomorphic mouse cell line, which 
expresses only 10% of normal type VII collagen, a 5’ RTM exchanging Col7a1 exons 1 to 15 was 
designed. In order to optimize the efficiency of 5’ trans-splicing, we specifically focused on the 
design of the RTM’s binding domain. We developed a GFP screening system which allows us to 
measure trans-splicing efficiencies in flow cytometry. With this system we selected highly efficient 
binding domains covering the endogenous Col7a1 exon/intron junction. For further optimization 
we eliminated in-frame termination codons within the binding domain, showing prevention of 
background expression of unspliced RTM in western blot analysis. Further, we were able to show 
accurate trans-splicing by increased expression levels of endogenous Col7a1 transcript in qPCR 
analysis as well as by elevated collagen VII protein expression in western blot analysis. In this study 
we show that RNA trans-splicing is a promising tool for exon replacement and can be significantly 
improved in terms of efficiency and safety while sustaining full functionality. The obtained data are 
of importance for future clinical applications of this technology.    
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Detection of common mutations in sporadic primary localized cutaneous amyloidosis by 
DNA mass spectrometry
Y Chang,2 C Lin,1 C Lee,2 M Lin,2 L Liu,3 C Chen,2 D Lee,2 H Liu,2 S Tsai1 and I Matsuura1 
1 National Health research Institutes, Zhunan, Taiwan, 2 National Yang-Ming University, 
Taipei, Taiwan and 3 Taipei Veterans General Hospital, Taipei, Taiwan
Primary localized cutaneous amyloidosis (PLCA) is a relatively common itchy skin disorder in 
South America and Southeast Asia. The disease is characterized histologically by focal deposition 
of amyloid in the dermal papillae of lesional skin resulting in severe itching and discolored macules 
or papules. The precise pathogenesis of PLCA is unclear, but it is considered to be multifactorial, 
involving both genetic and environmental contributions. The mutations of the genes for the com-
ponents of the interleukin-31 (IL-31) receptor, OSMRβ and IL31RA, were associated with patients 
of familial PLCA from previous whole-genome scan and candidate gene studies. To examine if the 
same mutations could also be found in sporadic cases of PLCA, we aimed to develop a mutation 
screen panel covering all known OSMRβ and IL31RA mutations in patients with PLCA. Archival 
skin biopsy specimens from 360 sporadic PLCA patients were recruited for the analysis. DNA 
extracted from formalin-fixed paraffin-embedded skin samples were analyzed by a new single 
base extension reaction with matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) 
technology. Among the 360 sporadic PLCA cases, 5 were identified with p.K697T mutation, 4 with 
p.P694L mutation, one with p.I691T mutation, and one with p.V631L mutation of the OSMR gene. 
Furthermore, one case was found to be positive with the IL31RA-S521F mutation. Together, 3.3% 
(12/360) of the PLCA was confirmed positive with a definitive genetic diagnosis. The average age 
at onset was earlier in PLCA patients carrying OSMR or IL31RA mutations than that in patients 
without a definitive genetic diagnosis (31.3 vs. 46.5 years). Our results confirmed the genetic factor 
in PLCA patients and identified the prevalent mutations from a retrospective study. This finding 
may have important implications in clinical practice as a molecular diagnostic tool of the disease.   
Genetic Disease, Gene Expression and Gene Therapy | ABSTRACTS
www.jidonline.org   S57
325
Disease Spectrum of Ichthyosis with Confetti
I Spoerri,2 M Brena,1 J De Mesmaeker,2 N Schlipf,4 J Fischer,4 G Tadini,1 P Itin3 and B Burger2 
1 Department of Pathophysiology and Transplantation, Fondazione IRCCS Cà Granda, 
Ospedale Maggiore Policlinico di Milano, Milano, Italy, 2 Department of Biomedicine, 
University Hospital Basel, Basel, Switzerland, 3 Department of Dermatology, University 
Hospital Basel, Basel, Switzerland and 4 Institute of Human Genetics, University Medical 
Center Freiburg, Freiburg, Germany
The aim of this study was to investigate clinical and genetic details of a substantial number of 
ichthyosis with confetti (IWC) patients in order to define major and minor criteria for diagnosis of 
this rare disease. IWC is a genodermatosis caused by dominant negative mutations in the keratin 
10 gene (KRT10). Small heterozygous deletions, insertions, or duplications within KRT10 lead to a 
frameshift and consequently to an arginine-rich C-terminus. Patients are born as collodion babies 
or with a generalized extensive erythema. During childhood numerous confetti-like patches of 
healthy skin begin to form. The adult cutaneous manifestation of IWC is a generalized scaly erythro-
derma interspersed with hundreds to thousands of confetti-like patches of healthy skin, where the 
pathologic mutation appears to be replaced by the wild type sequence through copy neutral LOH. 
Parallel clinical investigation of six IWC patients revealed a novel spectrum of phenotypes. Several 
features qualified as major criteria for diagnosis. Most importantly, they include malformation of 
ears, hypoplasia of mammillae, and dorsal acral hypertrichosis. Direct sequencing revealed different 
frameshift mutations in intron 6 or exon 7 of KRT10 in each patient. Here we present a phenotypic 
spectrum of IWC in six patients with confirmed mutation. Major and minor criteria deduced from 
these observations will improve diagnosis of IWC. Ectodermal malformations, which are present in 
all patients, suggest novel classification of IWC as a syndrome.    
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Dominant and recessive Olmsted syndrome with erythromelalgia due to TRPV3 mutations
S Duchatelet,1 S de Veer,1 L Guibbal,1 S Fraitag,2 P Nitschké,3 C Bole-Feysot,4 C Bodemer5 
and A Hovnanian1 1 Laboratory of genetic skin diseases, INSERM UMR1163, Imagine 
Institute of Genetic Diseases, Paris, France, 2 Department of Pathology, Necker-Enfants-
Malades hospital, Paris, France, 3 Bioinformatics Plateform, Imagine Institute of Genetic 
Diseases, Paris, France, 4 Genomics Plateform, Imagine Institute of Genetic Diseases, Paris, 
France and 5 Department of Dermatology, Necker-Enfants-Malades hospital, Paris, France
Olmsted syndrome (OS) is a rare keratinizing disorder characterised by extensive palmoplantar 
keratoderma (PPK) with clinical and genetic heterogeneity. Recently, TRPV3 (transient receptor 
potential vanilloid 3) missense mutations were identified in dominant and recessive OS. We report 
one sporadic and two familial cases of severe, atypical OS caused by new TRPV3 mutations. Our 
patients presented with progressive and severe nonmutilating PPK associated with intense erythro-
melalgia and no periorificial keratotic plaques. Exome sequencing identified a de novo p.Leu673Phe 
heterozygous missense mutation in the sporadic patient, a paternal p.Gly568Cys missense mutation, 
and a maternal splicing-site mutation within TRPV3 in the two affected brothers. Exome sequencing 
showed no mutation in SCN9A. The p.Leu673Phe and p.Gly568Cys mutations are located in the 
C-terminal region and the linker region between transmembrane helix 4 and 5 respectively. They 
involve highly conserved residues across species and are predicted to be damaging by in silico 
analysis. Structural data suggest less drastic consequences of the p.Gly568Cys mutation on chan-
nel function, consistent with its recessive inheritance pattern. The splicing-site mutation leads to 
in-frame skipping of exon 7, removing almost completely the third ankyrin repeat in the N-terminal 
domain (p.Gln216_Gly262del). The description of three new mutations, including the first defect 
in the N-terminal region, further implicates TRPV3 as a major gene in OS. The association with 
erythromelalgia expands the spectrum of clinical manifestations associated with TRPV3 mutations.   
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Founder mutation in epidermal dystonin underlying autosomal recessive epidermolysis 
bullosa simplex in Kuwait
T Takeichi,1 A Nanda,2 L Liu,3 K Sugiura,4 M Akiyama,4 H Al-Ajmi2 and JA McGrath1 
1 Dermatology, St John’s institute of Dermatology, London, United Kingdom, 2 As’ad 
Al-Hamad Dermatology Center, Kuwait, Kuwait, 3 Viapath, St Thomas’ Hospital, London, 
United Kingdom and 4 Dermatology, Nagoya University Graduate School of Medicine, 
Nagoya, Japan
Mutations in DST-e, encoding epidermal dystonin, also known as the 230-kDa bullous pemphigoid 
antigen (BP230), underlie some cases of autosomal recessive epidermolysis bullosa simplex (EBS). 
Thus far, 2 pathogenic homozygous nonsense mutations in DST-e have been reported; the affected 
pedigrees were Kuwaiti and Iranian. In this study, we identified 4 additional, seemingly unrelated, 
Kuwaiti families in which a total of 7 individuals had similar, predominantly acral, trauma-induced 
blistering since infancy, and skin biopsy evidence for a complete absence of BP230 immunore-
activity. We performed mutation analysis of DST-e and found that all affected individuals were 
homozygous for the mutation p.Gln1124*, the same mutation that was identified in the originally 
reported family from Kuwait. In addition, haplotype analysis defined a shared ancestral mutant DST-e 
allele among these 4 families and the previously reported Kuwaiti individual. Clinically, blistering 
in the homozygotes was life-long and most heterozygotes had no clinical abnormalities. However, 
one heterozygote had mild transient skin fragility during childhood, an observation noted in the 
previously reported Iranian pedigree, suggesting that the condition also may be semi-dominant in 
some pedigrees rather than purely autosomal recessive. In summary, we have identified 4 further 
EBS families from Kuwait in whom skin fragility is caused by a recurrent nonsense mutation in DST-
e, with implications for genotype-phenotype correlation as well as mutation detection strategies 
in this population.    
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Generation of induced Pluripotent Stem Cells (iPSCs) from Lymphedema Distichiasis Syn-
drome (LDS) for Establishment of Human Disease Model. 
M Itoh, S Kawagoe and H Nakagawa Dermatology, The Jikei University School of Medicine, 
Tokyo, Japan
Lymphedema-distichiasis syndrome (LDS, OMIM 153400) is a rare autosomal dominant disorder 
caused by the mutation in the FOXC2 gene, a family member of forkhead transcription factors. 
LDS is characterized by early or late-onset congenital lymphedema and distichiasis, i.e. multiple 
rows of aberrant eyelashes. Since FOXC2 protein is essential for development of the lymphatic and 
vascular systems, and also plays an important role in embryonic morphogenesis of several tissues, 
patients with LDS present not only with lymphedema but also with occasional varicose veins, 
congenital heart defects and other features. The pathogenesis of LDS is not well-defined, although 
mouse model has been developed. In 2006, the method for generating human induced pluripotent 
stem cells (iPSCs) has been established, and disease-specific iPSCs have been recently generated 
from several human diseases to develop cell and gene-based therapy and human disease model for 
investigating disease mechanisms. Therefore, we generated disease-specific iPSCs from monocytes 
isolated from a patient with LDS by exogenous expression of four reprogramming factors using 
Sendaivirus vector. We confirmed the authenticity of LDS-iPSCs by gene expression analysis of 
stem cell markers using RT-PCR and immunostaining. The differentiation capability of LDS-iPSCs 
was analyzed by the formation of embryoid body and teratoma. We are now trying to differentiate 
wild-type and LDS-iPSC into lymph vessel endothelial cells (LVECs) using several factors, including 
activin as a mesoderm initiator, BMP4 as an epithelial initiator and VEGFs as important factors for 
differentiating into endothelial cells.    
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Genetic polymorphisms associated to moderate to severe plaque psoriasis
G Solano-López,1 R Prieto-Pérez,2 F Abad Santos2 and E Daudén-Tello1 1 Dermatology, 
Hospital Universitario de la Princesa, Madrid, Spain and 2 Pharmacology, Hospital 
Universitario de la Princesa, Madrid, Spain
Psoriasis is a multifactorial chronic disease of the skin. In this study we aim to determine suscepti-
bility genes in patients with chronic moderate to severe plaque psoriasis and compare the analyzed 
polymorphisms with healthy controls. We analyzed 173 single nucleotide polymorphisms of genes 
related with psoriasis and other autoimmune diseases in 191 moderate to severe plaque psoriasis 
patients and 197 healthy controls. All participants are Caucasians and 24% of the patients have 
psoriatic arthritis. Results of the multivariate logistic regression analysis showed 9 single nucleotide 
polymorphisms associated with psoriasis: PTPN22, CD226, TYK2, IL12B, IL1A, SLC22A4, TNFAIP3, 
HLA-C and IκBKβ genes. Comparing patients without psoriatic arthritis (n=145) versus controls, 
we found 8 single nucleotide polymorphisms previously associated with psoriasis and other 7 in 
IL18, CLMN, CTNNA2, RNF114, IL12B, MAP3K1 and CCHCR1 genes that may be specific for the 
development of psoriasis in our population. Our findings show the importance of genes related 
with the immune system for the developing of moderate-to-severe psoriasis.    
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Germline mutation in EGFR resulting in epithelial inflammation and metabolic abnormalities. 
P Campbell,1 PE Morton,2 T Takeichi,1 N Roberts,3 MA Simpson,4 M Parsons2 and 
JA McGrath1 1 St John’s Institute of Dermatology, King’s College London, London, United 
Kingdom, 2 Randall Division of Cell and Molecular Biophysics, King’s College London, 
London, United Kingdom, 3 Department of Paediatrics, Chelsea and Westminster Hospital 
NHS Foundation Trust, London, United Kingdom and 4 Department of Medical and 
Molecular Genetics, King’s College London, London, United Kingdom
A 12 month old Eastern European male infant from a consanguineous Roma family presented with 
multi-organ epithelial inflammation and electrolyte imbalance of unknown aetiology. Clinically, 
he had skin erosions, dry scale, and alopecia, but later developed a papulopustular rash. He died 
aged 2.5 years from sustained metabolic abnormalities compounded by skin and chest infections. 
Collectively, the clinicopathological features suggested a novel genodermatosis. Whole-exome 
sequencing disclosed a homozygous loss-of-function missense mutation within EGFR (c.1283G>A; 
p.Gly428Asp), encoding the epidermal growth factor receptor (EGFR). Immunolabelling for EGFR 
in the patient skin showed cytoplasmic rather than membranous localisation, and transfection of a 
mutant p.Gly428Asp construct into MCF7 cells (that express low endogenous EGFR) demonstrated 
that mutant EGFR at the plasma membrane was highly unstable and more susceptible to constitutive 
endocytosis. Upon ligand stimulation (with EGF) the mutant receptor showed a lack of both EGFR 
phosphorylation and activation of downstream signalling pathways. Microarray analysis of skin 
RNA identified disturbed terminal differentiation and raised expression levels of several inflam-
matory/innate immune response transcripts. Together, these results provide strong support for the 
pathogenicity of the EGFR mutation. This new autosomal recessive genetic disorder reflects the 
protean role of EGFR in human development and tissue homeostasis. The findings also reveal the 
pathophysiological abnormalities arising from global disruption of EGFR signalling, observations 
that are relevant to the cutaneous and extra-cutaneous side-effect profile seen in oncology patients 
receiving EGFR inhibitor drugs or antibody therapies.    
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Homozygous missense mutation in IL36RN in generalized pustular dermatosis compatible 
with both AGEP and generalized pustular psoriasis 
AA Navarini,2 MA Simpson,2 N Yawalkar1 and C Schlapbach1 1 Department of Dermatology, 
University of Bern, Bern, Switzerland and 2 Division of Genetics & Molecular Medicine, 
King’s College London, London, United Kingdom
Acute generalized pustular eruptions (AGEP) and generalized pustular psoriasis (GPP) show many 
overlapping clinical features. Here we report a 40 years old man who initially presented with 
generalized pustules and systemic inflammatory response syndrome 5 days after intake of amox-
icillin, suggesting a diagnosis of AGEP due to amoxicillin. Nine months later, a throat infection 
was followed by a generalized pustular skin reaction with systemic symptoms without prior drug 
intake. Clinical presentation and histology was compatible with the diagnosis of GPP, and the 
patient recalled a similar episode 20 years before. Retrospectively, our initial diagnosis of AGEP 
was therefore called into question, as drug-triggered GPP was now the likely diagnosis. However, 
based on current classification systems, it remains unclear whether such cases should be diagnosed 
as AGEP or drug-elicited GPP. Genetic analysis of this patient identified a homozygous mutation 
in exon 5 (c.C338T:p.S113L) of the IL36RN gene. The IL36RN gene encodes the anti-inflammatory 
IL-36-receptor antagonist, IL-36Ra, which blocks the pro-inflammatory cytokine IL-36. IL36RN 
mutations can lead to uncontrolled IL-36 signaling and enhanced production of IL-6, IL-8, and IL-1 
which give rise to pustular eruptions. Recent findings show that IL36RN variants are common in GPP 
without plaque psoriasis and that they can be found in a subset of AGEP. In this case, the IL36RN 
mutation therefore underlies the generalized pustular eruptions and provides the pathogenetic link 
between the clinically overlapping presentation of AGEP and GPP. It is likely that in our patient 
stimulation of the immune system, be it by drug hypersensitivity to amoxicillin or throat infection, 
led to uncontrolled neutrophilic skin inflammation because of deficiency in IL-36RA. Moreover, 
our case supports the emerging concept that the disease taxonomy of pustular skin eruptions could 
in future be based on genetic profiling.    
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Ichthyosis linearis circumflexa as the only clinical manifestation of Netherton syndrome 
L Guerra,1 P Fortugno,2 C Pedicelli,3 V Proto,2 G Zambruno1 and D Castiglia1 1 Laboratory 
of Molecular and Cell Biology, Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome, Italy, 
2 Dermatology Division, Bambino Gesù Children’s Hospital-IRCCS, Rome, Italy and 3 Day 
Hospital Service, Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome, Italy
Netherton syndrome (NS) is a rare autosomal recessive keratinization disorder due to SPINK5 
mutations that cause absent or, rarely, reduced expression of the serine protease inhibitor LEKTI. NS 
is characterized by the triad of (i) congenital ichthyosiform erythroderma in most cases associated 
with ichthyosis linearis circumflexa (ILC), (ii) a pathognomonic hair shaft defect called trichorrhexis 
invaginata and (iii) atopy manifestations. ILC consists of migratory, annular and polycyclic scaling 
patches with double-edged scales at the periphery of the lesions. We studied two young siblings 
who presented, since the first months of life, erythematous areas on the cheeks followed by the 
appearance of sparse ILC lesions on the face, trunk, buttocks and proximal extremities, with a remit-
ting and relapsing course. Erythroderma at birth, trichorrhexis invaginata and atopic manifestations 
were absent and IgE levels were normal. LEKTI immunoreactivity was present in the granular layer 
and hair follicle in patient skin, although markedly weaker than in control skin. In situ zymography 
indicated a modest increase of the serine protease activity in the epidermis. Subsequent analysis of 
the SPINK5 sequence revealed compound heterozygosity for the c.1302+4A>T and c.2240+1G>A 
splice-site mutations. Gene expression studies performed in patient keratinocytes revealed that the 
mutation combination correlated with a normal pattern of bioactive LEKTI fragments, which however 
were released at lower levels and with a different relative abundance compared to normal cells. Our 
results show that ILC can be the only clinical manifestation of NS, resulting from specific SPINK5 
mutation combinations that lead to reduced LEKTI expression. They also point to the relevance of 
SPINK5 mutation analysis to recognize non-classical NS forms and properly counsel the families.   
334
Internal exon replacement as a promising tool for COL7A1 RNA repair
C Hüttner, S Hainzl, EM Murauer, JW Bauer and U Koller Department of Dermatology, 
Division of Experimental Dermatology and EB House Austria, Paracelsus Medical University, 
Salzburg, Austria
In recessive dystrophic epidermolysis bullosa (RDEB) mutations are located within the gene COL7A1 
encoding for type VII collagen. Truncated or loss of collagen VII protein results in severe blistering 
of the skin and mucous membrane which are hallmarks of this inherited skin disease. The aim of 
this work is the replacement of mutated COL7A1 exons using the combination of 5’ and 3’ RNA 
trans-splicing also called internal exon replacement (IER). The size-associated limitations which are 
known in gene therapy could be avoided using IER. A double RNA trans-splicing molecule (dRTM) 
includes splicing elements for efficient trans-splicing, two binding domains (BD) binding up- and 
downstream of the mutated gene region and the wildtype coding exon(s) for exchange. We have 
established a fluorescence reporter-based screening system in order to select highly efficient dRTMs 
out of a pool of randomly designed individual dRTMs. In this setup the reporter molecule AcGFP 
was split up into three parts. The internal part of AcGFP was included in the RTM whereas the 5’ 
and 3’ end of the reporter were cloned into an artificial target molecule containing the mutated gene 
region of COL7A1. Co-transfection experiments in HEK293 cells revealed a highly efficient dRTM 
capable to induce GFP expression in over 70% of all analyzed cells. We were able to confirm the 
full restoration of the reporter molecule GFP on protein level by Western blot analysis after IER. This 
dRTM can then be adapted for further endogenous experiments in RDEB patient cells. We assume 
that the methodology of internal exon replacement is a promising tool to correct mutations in the 
gene COL7A1 involved in the severe blistering skin disease epidermolysis bullosa.    
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Lamina lucida cleavage pattern analysis in junctional epidermolysis bullosa: insights that 
facilitate the diagnosis 
I Turcan and MF Jonkman Centre for Blistering Diseases, Department of Dermatology, 
University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
Mutations in genes coding for laminin 332, type XVII collagen and α6β4 integrin cause junctional 
epidermolysis bullosa (JEB). The cleavage plane (level of tissue separation) is within lamina lucida. 
The objective of this study is to investigate the value of lamina lucida cleavage pattern analysis in 
JEB. Skin biopsies of JEB patients (n=24) were analyzed by means of immunofluorescence antigen 
mapping (IFM). The results were correlated with electron microscopy (EM). Molecular analysis of 
all cases was performed. Investigation of immunofluorescence patterns in JEB reveals two types 
of lucidolytic cleavage: a low lamina lucida cleavage and a high lamina lucida cleavage. Muta-
tions in type XVII collagen or α6β4 integrin cause a high junctional cleavage, while mutations in 
laminin 332 lead to a low junctional cleavage. An additional clue to diagnosis is that mutations 
in type XVII collagen lead to loss or reduction of apical-lateral cell staining in the epidermal basal 
cell layer. These observations increase the insight into the topographic level of blister formation 
and staining patterns in JEB. The main implication is that IFM allows for easy and straightforward 
identification of the candidate gene(s), even in cases where staining is not clearly reduced, thus 
facilitating the diagnosis.    
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Lentiviral-mediated gene editing for correction of COL7A1 deficient RDEB
C Georgiadis,1 D Almarza,2 AO Thrasher,1 JA McGrath,3 W Qasim1 and W Di1 1 Molecular 
and Cellular Immunology, Institute of Child Health, UCL, London, United Kingdom, 2 
Fondazione Banca degli Occhi del Veneto, Venezia, Italy and 3 St. John’s Institute of 
Deramatology, London, United Kingdom
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare and debilitating genodermatosis with 
neonatal onset caused by mutations in the COL7A1 gene resulting in non-functional type VII colla-
gen protein (C7) leading to severe blistering and tissue separation at the dermal epidermal junction. 
Here we report the use of zinc finger nucleases (ZFN) to edit genomic COL7A1 and restore protein 
expression. ZFNs were designed to bind exon 4 of COL7A1 where several hot-spot mutations have 
been reported. ZFNs are typically delivered via DNA or mRNA transfection in most cell types but 
with very low efficiency in primary keratinocytes (KC). To improve delivery of these DNA-binding 
motifs, we have subcloned both aspects of the ZFN pairs into a non-integrating lentiviral vector 
(NILV) allowing for their transient expression in cells, therefore reducing the risk of insertional 
mutagenesis. The efficiency of editing in KC using the NILV-ZFNs resulted in a 25% modification 
compared to 12% when using plasmid ZFN transfection. Clonal expansion revealed 20.8% monoal-
lelic and 4.2% biallelic disruption of the gene. This was further confirmed by the detection of C7 
protein expression showing a proportional reduction in cells with monoallelic change and absence 
in cells with biallelic gene editing compared to normal levels positively correlating with in-vitro 
cell migration functional assays. A NILV carrying endogenous dsDNA donor gene repair template 
sequence was designed and delivered to ZFN-treated KC cells. Sequencing across the ZFN binding 
site is expected to reveal both monoallelic and biallelic template insertion by targeted homologous 
recombination. Our results show an improved method for ZFN and template delivery to KC using 
viral vectors demonstrating the feasibility of a patient-tailored gene editing strategy for the correction 
of COL7A1 and restoration of C7 expression.    
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LESIONAL PSORIATIC SKIN: A COMPREHENSIVE ANALYSIS OF GENE EXPRESSION 
A Mezentsev, A Zolotarenko, A Soboleva and S Bruskin Functional Genomics, Federal Non-
profit Research Institution of Russian Academy of Sciences, NI Vavilov Institute of General 
Genetics, Moscow, Russian Federation
Psoriasis is an immune-mediated skin condition with a genetic predisposition. Aim of this paper was 
to provide a comprehensive analysis of the transcriptome in lesional psoriatic skin. Using bioinfor-
matic approaches we analyzed gene expression in the skin samples subjected to microarray (MA) 
and next generation sequencing study (NGS). Comparative analysis of the named datasets revealed 
differences in expression of genes that had a role in terminal differentiation and hyperproliferation 
of epidermal keratinocytes, antimicrobial peptides and protease inhibitors. We also confirmed the 
elevated expression of the following Th1 cytokines: IL12A, IL12B, IL17A, IL17F and TNF. Notably, 
upregulation of TNF was reported for a NGS dataset for the first time. Moreover, we described three 
gene clusters with a coordinated gene expression. One of these clusters, the complex of epidermal 
differentiation genes was also known as the psoriasis susceptibility locus PSORS4. In addition, the 
analysis of NGS data revealed more than 60 differentially expressed genes in lesional skin. Interest-
ingly, these 60 genes were differentially expressed in all lesional samples suggesting that this gene set 
can be used for diagnosing proposes by comparing two paired biopsies of lesional and uninvolved 
skin taken from the same patient. The comparative analysis of whole-genome data suggests NGS 
as the most reliable method to characterize gene expression in psoriatic lesional skin. The data 
analysis revealed several gene sets with coordinated expression. Notably, each of the mentioned 
gene sets was composed of the genes with a common function. Moreover, we proposed a molec-
ular signature for sorting the samples of lesional and uninvolved skin. The later can be helpful for 
diagnostic proposes as well as for evaluation of new experimental drugs.    
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MAD-AD: A meta-analysis derived atopic dermatitis transcriptome
A Ewald,1 T Litman,2 J Correa-Da Rosa,1 JG Krueger,1 E Guttman1 and M Suarez-Farinas3 
1 Rockefeller University, New York, NY, 2 Biological Research, LEO Pharma A/S, Ballerup, 
Denmark and 3 Mount Sinai School of Medicine, New York, NY
Atopic dermatitis (AD) is a common inflammatory skin disease with limited treatment options due to 
incomplete understanding of its pathogenesis. Transcriptomic profiling of lesional (AL) and non-le-
sional (ANL) AD skin has been performed by microarray analysis to generate a ”genomic disease 
signature”. Although these experiments have shed some light on the pathology of AD, inter-study 
comparisons reveal large differences in the resulting sets of differentially expressed genes (DEGs), 
limiting the utility of direct comparisons of DEGs across studies. In this work we applied novel 
meta-analysis models to combine four AD microarray datasets from published/submitted studies. 
Raw data was uniformly preprocessed and batch-adjustment was conducted prior to the analysis. 
Taking into account within-study variation, a fixed-effect model was applied to 110 samples (60 
AL and 50 ANL;47 paired), to define a robust disease profile. This resulted in a comprehensive AD 
transcriptome with 576 DEGs (at FCH>2, adj.p-values<0.05), with 370 up- and 206 down-regulated 
genes in AL versus ANL samples. We identified 108 new DEGs (57 up, 51 down) significantly 
enriched for GO-terms related to epidermal surface lipids and fatty acids. Ingenuity Pathway Anal-
ysis (IPA) on these new DEGs revealed enrichment for genes related to Granulocyte Adhesion and 
Diapedesis and Atherosclerosis Signaling.    
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Marked intrafamilial variability in dystrophic epidermolysis bullosa caused by dominant and 
recessive COL7A1 mutations 
S Turczynski,1 M Titeux,1 N Pironon,1 DF Murrell2 and A Hovnanian1 1 Laboratory of genetic 
skin diseases, INSERM UMR1163, Imagine Institute of Genetic Diseases, Paris, France and 2 
St George Hospital, Sydney, NSW, Australia
Patients suffering from dominant or recessive dystrophic epidermolysis bullosa (DDEB/RDEB) 
develop clinical signs ranging from minor to extensive skin blistering with the severest forms being 
life-threatening. The different subtypes result from mutations in COL7A1 encoding type VII collagen 
(C7) that forms anchoring fibrils (AF) at the dermal-epidermal junction. We present the case of two 
siblings displaying a severe generalized form of DEB contrasting with mild DDEB segregating on 
their mother’s side for several generations. The DDEB relatives had dystrophic toenails and minor 
blistering on the legs. In contrast, gradually after birth, both siblings developed extensive skin ero-
sions, numerous milia, and marked skin atrophy, with oesophageal stricture, fusion of digits and 
growth retardation. The older brother died at the age of 8.5 years from cardiomyopathy. Immuno-
fluorescence mapping of the siblings skin showed marked reduction of C7 staining. Ultrastructural 
examination of the skin of a DDEB relative displayed slightly abnormal AF. In contrast, AF were 
rudimentary and rare in the two siblings. Sequencing of COL7A1 revealed a single dominant hetero-
zygous mutation c.6698G>A (p.Gly2233Asp) in exon 84 in the two siblings and in all DDEB tested 
family members. Analysis of COL7A1 transcripts led to the identification of a novel deep intronic 
mutation IVS19+40G>A at the heterozygous state in the two siblings and their healthy father. This 
latter strengthens a cryptic donor splice site causing retention of the first 37 nucleotides of intron 
19, leading to a premature stop codon. Here we show that the p.Gly2233Asp mutation, known 
to cause a transient form of DDEB, can lead to minor but persistent blister formation at adulthood 
and that its cosegregation with a newly identified deep intronic recessive mutation causes severe 
generalized DEB, which elucidates the disease variability observed in this family.    
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Modelling, understanding and treating hyperpigmentation phenotype associated to neurofi-
bromatosis type 1 using embryonic stem cells
J Allouche,1 N Bellon,1 G Lemaître,1 C Delevoye,2 M Peschanski1 and C Baldeschi1 1 ISTEM, 
INSERM U861, Evry, France and 2 Institut Curie, CNRS, UMR 144, Paris, France
Neurofibromatosis type I (NF1) is one of the most common autosomal dominant transmitted neuro-
cutaneous disorder. NF1 is caused by loss-of-function of the tumour suppressor gene NF1 encoding 
neurofibromin, a negative regulator of RAS proteins. Despite of the wide clinical expression spec-
trum, NF1 affects essentially cells and tissues derived from neural crest. Hyperpigmentation and 
“café au lait macules” apparition is one of the characteristic disorder patterns in all patients in the 
first years of life. To reveal and understand the molecular mechanisms associated with the loss of 
neurofibromin on pigmentation phenotype, we took advantage that human embryonic stem cells 
(hESC) possess the capacity to differentiate into a wide variety of cell types including melanocytes. 
Melanocytes derived from two hESC carrying the same NF1 mutation, leading to a decrease of the 
native form of neurofibromin expression, presents a hyperproliferative status and a hyperactivation of 
MAPK pathways and cAMP-mediated protein kinase A activity. These mysregulation correlates with 
an increased expression of the proteins implicated in the melanogenesis leading to an accumulation 
of matures melanosomes containing melanin. This hyperpigmentation phenotype could by reverted 
using inhibitors. Using embryonic stem cells carrying NF1 mutation we have revealed molecular 
mechanisms leading to an hyperpigmentation phenotype in melanocytes. This finding highlights 
the possibility of targeting NF1 associated proteins for therapeutic treatment.    
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Modulating UVB induced apoptosis in Kindler sydrome keratinocytes
K Maier, Y He, U Wölfle, S Löffek, L Bruckner-Tuderman and C Has Dermatology, Medical 
Center - University Freiburg, Freiburg, Germany
Kindler syndrome (KS) is a recessively inherited skin disorder caused by mutations in the FERMT1 
gene encoding kindlin-1, a phosphoprotein involved in β1 integrin activation at focal adhesions, cell 
cycle and stem cell regulation. KS manifests first with skin blistering and photosensitivity, followed 
by progressive poikiloderma and mucosal involvement. Here, we addressed the mechanisms of 
photosensitivity in KS by exploring the effects of UVB irradiation on kindlin-1 negative immortal-
ized keratinocytes from patients with KS (KSK) in vitro. Compared to normal human keratinocytes 
(NHK), survival of KSK after UVB irradiation is significantly reduced in a dose dependent manner, 
due to reduced cell proliferation (~10% less proliferating cells, p<0.01) and increased apoptosis 
(~2.5 fold, p<0.05). We analysed factors and pathways known to be involved in UVB response, 
and found sustained increase in p38 phosphorylation (Pp38, ~2 fold, p<0.05) and significantly 
elevated mRNA levels of TNF-α (~4 fold, p<0.05) in KSK compared to NHK. Phosphorylation of 
ERK1/2 and AKT, as well as gene expression levels of TGFβ1, TGFβ2 and IL1α were comparable to 
the control cells. To address direct involvement of Pp38 and TNF-α in UVB induced apoptosis in 
KSK, the cells were treated with the specific inhibitor of p38 phosphorylation, SB203580, and the 
TNF-α blocking antibody TNFR before UVB irradiation, and apoptosis was measured by TUNEL and 
caspase activation (ApoOne) assays. These treatments significantly (p<0.05) reduced UVB induced 
apoptosis in KSK from two KS patients. In addition, the plant extract luteolin, which is known to 
block p38 phosphorylation and is used in topical applications for sensitive skin, had similar effects. 
Increasing kindlin-1 expression level in kindlin-1 negative KSK to about 10% of normal controls, 
significantly reduced UVB induced apoptosis, whereas overexpression of kindlin-2 had no effect. 
These data uncovered a novel role of p38 and TNF-α in the UVB response in KS, thereby identifying 
them as potential targets for therapeutic interventions.    
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Molecular and morphological Characterization of the inflammatory Infiltrate in Rosacea: 
new Insights into immune Pathophysiology
M Sulk,1 P Nowak,2 J Buddenkotte,2 F Cevikbas,1 C Kempkes,1 J Aubert,3 JJ Voegel,3 
M Steinhoff4 and T Buhl5 1 Dermatology, UCSF, San Francisco, CA, 2 Dermatology, UKM, 
Münster, Germany, 3 Molecular Dermatology, Galderma R&D, Sophia Antipolis, France, 4 
Charles Institute for Translational Dermatology, UCD, Dublin, Ireland and 5 Dermatology, 
UMG, Göttingen, Germany
Rosacea is a chronic inflammatory skin disease of unknown etiology. Thus, the treatment for rosacea 
is often only symptomatic and a deeper insight into the exact pathophysiology is needed. Therefore, 
we performed a detailed transcriptome analysis of relevant genes in rosacea subtypes (erythemato-
telangiectatic: ETR, papulopustular: PPR, and phymatous: PhR), compared to non-lesional or healthy 
skin. Here, we focused on the genes involved in innate or adaptive immunity, and characterized 
the inflammatory infiltrate using immunohistochemistry. In all rosacea subtypes, the T cell marker 
CD3 was increased on gene level. Using immunohistochemistry and morphometry, we found an 
increased infiltrate of CD4+ T cells in ETR and PPR, in particular T helper 1 (TH1) and T helper 17 
(TH17) cells. In contrast, molecular markers for B cell activation were only occasionally increased, 
and immunohistochemistry confirmed B cells to be only occasionally localized in single patients 
with PPR or PhR. High expression levels of chemokines and cytokines known to be involved in 
immune cell recruitment and activation of macrophages and mast cells were also observed. In 
sum, the immune response in rosacea shows a TH1/ TH17 expression profile, although slight differ-
ences between each subtype exist. Moreover, B cells are only occasionally observed, indicating 
different trigger factor leading to rosacea. Of innate immune cells, macrophages and mast cells 
were abundantly present, neutrophils only in pustules, correlating well with transcriptome data. No 
differences were found for Langerhans cells, NK cells or basophils in rosacea patients compared 
to controls. Our data give a better understanding about the underlying immune pathways in the 
pathophysiology of rosacea that may lead to novel, more specific therapies for this frequent chronic 
inflammatory skin disease.    
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MSX1   mutation in Witkop syndrome with a new phenotype: a case report of new Syndrome 
F Ghaderi,1 R Ghaderi,2 S Hekmatfar1 and M Fardaei1 1 Shiraz University of Medical 
Sciences, Shiraz, IRAN, Shiraz, Islamic Republic of Iran and 2 Dermatology, Birjand 
University of Medical Sciences, Birjand, Islamic Republic of Iran
~~Witkop syndrome is a rare autosomal dominant disorder characterized by the absence of several 
teeth and abnormalities of the nails. This is the first report of a rare genetic tooth and nail syndrome 
(TNS) diagnosed in a 2.5-year-old boy with a mutation in 3’-UTR of the MSX1 gene associated 
with the absence of the incisors, early exfoliation of the canines in primary dentition, and toe-nail 
dysplasia. n clinical examination, all the maxillary and mandibular primary incisors were missing. 
His parents stated that the primary incisors of their child had not erupted yet. Extraoral examination 
revealed lip eversion and fine hair, while the eyebrows and eyelashes were normal. No heat intol-
erance or any inability to sweat was reported. The toenails were spoon-shaped and hypoplastic. 
Periapical radiography showed primary anterior germs. Regarding the early exfoliation of the primary 
canines, a diagnostic test was requested to determine the levels of serum alkaline phosphatase and 
urinary phosphoethanolamine, but no abnormality was reported. Also in this study, we propose a 
simple Avall enzyme digestion for the analysis of this particular mutation.The parents of the patient 
had no dental and nail anomalies. In present case we focused on chief complaints of patient (early 
exfoliation of primary canine teeth). This finding was not reported in witkop syndrome yet. The full 
article of this case was printed in Iranian Medical sciences Journal in 2013.    
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New modulated genes in psoriasis-derived keratinocyte subpopulations. 
R Lotti,1 E Tenedini,2 A Fabiano,3 F Truzzi,1 A Saltari,1 P Morandi,1 A Marconi1 and 
C Pincelli1 1 CHIMOMO, University of Modena and Reggio Emilia, Modena, Italy, 2 Life 
Sciences, University of Modena and Reggio Emilia, Modena, Italy and 3 Medicine, University 
of Modena and Reggio Emilia, Modena, Italy
T cells play a crucial role in the pathogenesis of psoriasis, recent data emphasize the key role of 
keratinocytes that, by carrying intrinsic alterations, could determine the formation of skin lesions 
resembling psoriasis, without the participation of T-cell derived cytokines. In particular, transit 
amplifying (TA) cells, the stem cell progeny, seems to be responsible for the psoriatic phenotype. 
The aim of this study was to analyze the role of keratinocytes sub-populations in the pathogenesis 
of psoriasis. We analyzed the gene expression profile (GEP) of human keratinocyte sub-populations 
(stem, “early” TA (ETA) and “late” TA (LTA) cells), derived from healthy skin, lesional and non-le-
sional psoriatic skin. The total RNA samples, extracted from keratinocyte subpopulations immedi-
ately after separation, were hybridized onto the Affymetrix human U133 plus 2.0 GeneChip Array. 
We identified a small number of up-regulated genes (12 probe sets, corresponding to 8 genes) in 
keratinocyte subpopulations derived from lesional psoriasis vs. healthy and non-lesional psoriasis. 
We confirmed the increased expression levels of TCN1, S100A7A, KYNU, SERPINB13, FOXE1, 
but solely due to the keratinocyte component. We identified for the first time the up-regulation of 
TMEM171, CLEC7A and NDRG4, which seems to correlate with the pathophysiology of psoriasis. 
Moreover, GEP analysis of lesional psoriasis sub-populations, as compared to the non-lesional 
psoriatic counterpart revealed the modulation of 17 probe sets, corresponding to 13 genes. Among 
these genes, we recognized for the first time the up-regulation of IL13RA1, CCDC109B and CD47. 
These results indicate the importance of keratinocyte compartment in psoriasis, opening the way 
to the study of new genes potentially critical in the pathogenesis of psoriasis.    
345
New transgenic RDEB mouse model using editing of COL7A1 genomic sequence
J Jackow, M Titeux and A Hovnanian Laboratory of genetic skin diseases, Inserm UMR 1163 
and Imagine Institute of Genetic Diseases, Paris, France
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe genetic skin fragility disorder caused 
by mutations in the COL7A1 gene, encoding type VII collagen, which stabilizes the dermal-epider-
mal junction. There is no specific treatment and several approaches using gene, cell and protein 
therapies are currently being developed. In order to demonstrate the efficacy of these approaches 
in vivo, viable animal models that recapitulate the human disease are needed. We are developing a 
new transgenic mouse carrying a recurrent hypomorphic COL7A1 recessive mutation in exon 80. To 
engineer selected mutations in the human COL7A1 genomic sequence, we have established an effi-
cient “scare less” method using genome editing by a two steps homologous recombination strategy 
on bacterial artificial chromosome. In the first step, the targeting construct 1 contains a selectable 
Neo cassette and homology arms identical to the targeted COL7A1 sequence but containing the 
desired mutation. In the second step, the targeting construct 2 contains a non-selectable COL7A1 
fragment which is exchanged with the selectable COL7A1 sequence from step 1. The clones in 
which the COL7A1 DNA is correctly targeted are selected for loss of kanamycin resistance. We 
could demonstrate integration of the selection cassette into the COL7A1 gene and its subsequent 
removal by size shift of DNA fragments obtained by PCR amplification using primers flanking the 
modified exon. Further sequence analyses confirmed the introduction of the desired mutation and 
integrity of the genomic sequence near exon 80. A linear fragment containing the entire mutated 
human COL7A1 genomic sequence was used to generate transgenic animals. These animals will 
be characterized and crossed with Col7a1 knockout mice to generate an RDEB mouse model con-
taining the human COL7A1 with the desired mutation. Here we demonstrated an efficient strategy 
to introduce specific mutations in COL7A1 that can be used to generate new models for in vivo 
testing of relevant therapeutic approaches for RDEB.    
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Normal human adipocytes gene expression profiling using a robotic workstation coupled 
to microarrays
F Pellicier, J Franchi, V Jeronimo-Monteiro, K Lazou, C Marteau, O Jeanneton, R Kurfurst and 
S Schnebert LVMH Recherche, Saint Jean de Braye, France
Adipocytes are involved in several biological mechanisms such as lipid, glucose metabolism and 
endocrine functions. They also secrete adipokines which act as classic circulating hormones to com-
municate with other organs. In order to better understand the regulation of gene expression involved 
in the main molecular pathways of adipocyte metabolism, the objective of this work was to develop 
an automatized protocol allowing us to quantify gene expression in normal human adipocytes and 
to study their modulation under different treatment conditions. A custom designer gene card based 
on the sensitive TLDA technology (TaqMan Low Density Arrays) is used. The gene card contains 22 
genes chosen from their known function associated with adipokines, lipid metabolism, and fatty acid 
oxidation. The microarrays were processed using an automate sample preparation (MicrolabStar, 
Hamilton) which allowed us to perform RNA extraction, RNA quantification/normalization of the 
samples and the reverse transcription step. The TLDA microarrays were loaded with the different 
samples tested in triplicate and used for real-time PCR reaction. Results are expressed in Relative 
Quantification (RQ). To evaluate the repeatability of our protocol, 4 independent mature adipocyte 
cultures were performed and each culture was treated for 24 hours with Forskolin 10μM. Forskolin is 
known to act directly on targets involved in lipolysis and adipogenesis and its effects are compared 
to basal gene expression obtained from untreated adipocytes. The results show that Forskolin is 
able to modulate the expression of 15 genes, among them, for example, Adiponectin, MCP-1 and 
Hormone Sensitive Lipase genes are upregulated and AQP7 and UCP2 genes are downregulated in 
a repeatable manner and in accordance with the literature. Forskolin is considered as our positive 
control in this new automatized tool associated with a robust experimental protocol to screen active 
ingredients for lipolytic and adipogenetic projects in the cosmetic field.    
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Novel cryptic splice acceptor site activating mutation in the LAMB3 gene with founder effect 
causes serial Herlitz-type junctional epidermolysis bullosa
B Mayer,1 P Silló,1 M Mazán,1 D Pintér,1 M Medvecz,1 Z Hatvani,1 G Bárány,2 H Pamjav2 and 
S Kárpáti1 1 Department of Dermatology, Venereology and Dermatooncology, Semmelweis 
University, Budapest, Hungary and 2 Institute of Forensic Medicine, Budapest, Hungary
Recently, we encountered a high incidence of recessive lethal Herlitz-type junctional epidermolysis 
bullosa (HJEB) in infants born to Hungarian Roma parents residing in a small area. The diagnosis 
was confirmed in two newborns who lacked functional laminin 332 in the cutaneous basement 
membrane. Sequencing the genomic DNA, a novel G>A mutation was discovered in Intron 10 of 
the LAMB3 gene. The mutation activates a cryptic splice acceptor site and leads to the insertion 
of a short fragment from Intron 10 into the mRNA between Exons 10 and 11. All five of the infants 
with HJEB studied were homozygous for the mutation and their parents were heterozygous carriers. 
Sequence analysis of the cutaneous LAMB3 mRNA in one newborn let us define the effects of the 
abnormal splicing: a Ser-Leu substitution and a hexapeptide inclusion with frameshift and PTC 
in Exon 11. When we obtained family histories from the affected families, we found that 8 more 
babies had died of severe skin blistering at early ages. The rate of consanguinity was quite high 
in this community as was the carrier rate of the mutant allele: among 64 individuals screened, 30 
were carriers. Using Y chromosome H1a-M82 haplogrouping and its haplotyping, two male HJEB 
newborns and 5 fathers from the affected families were found to be Romungro as are majority of 
the Roma in Hungary. The LAMB3 mutation does not appear to be common in Roma however; 
it was not found in any of the 306 unrelated Hungarian Roma tested. To determine the age of 
this founder mutation, we constructed a median joining haplotype network within the H1a-M82 
haplogroup. The estimated age of the mutation is 548±222 years (95% CI, 326-770 years calcu-
lated with 25 years per generation), while Roma have been in Hungary for about 500-600 years. 
Mutation screening and genetic counseling are now available to prevent further lethal HJEB cases 
in the isolated community where we worked.    
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Novel FERMT1 Mutations in Consanguineous Iranian Families with the Kindler Syndrome
L Youssefian,1 H Vahidnezhad,1 Q Li,2 A Kajbafzadeh,1 M Tabrizi,1 M Barzegar,3 S Sotoudeh1 
and J Uitto2 1 Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran, 2 
Jefferson Medical College, Philadelphia, PA and 3 Shahid Behesti University of Medical 
Sciences, Tehran, Islamic Republic of Iran
The Kindler syndrome (KS) is a rare autosomal recessive genodermatosis characterized by diffuse 
poikiloderma, cutaneous atrophy, acrokeratosis, trauma-induced blisters and photosensitivity. Muta-
tions have been previously disclosed in the FERMT1 gene which encodes kindlin-1, a component 
of keratinocyte focal adhesions. The incidence of KS is expected to be high in Iran due high rate 
of consanguineous marriages. We identified a total of 13 Iranian families with KS, including 40 
affected individuals. Pedigree analysis of these families suggested high degree of consanguinity. 
The patients demonstrated characteristic clinical features, while the parents, obligate heterozygote 
carriers, were clinically unaffected. Mutation analysis of FERMT1 by amplification of all 15 exons 
and flanking intronic sequences, followed by bidirectional sequencing, revealed homozygous non-
sense mutations, both recurrent and novel, including c. 1176T>G, c.1383C>A, c.550_551insA, 
[c. 889 A>G,c.1139+2 T>C], c.957+1G>A, c994_995delCA, and c.910G>T. One of the novel 
mutations is missense, two are splice site mutations and all the remaining five mutations cause 
premature termination codons. These previously unpublished mutations in the FERMT1 gene expand 
the spectrum of the mutations underlying KS. The identified mutation database forms the basis to 
confirm the clinical diagnosis by genetic testing and to identify heterozygous carriers, coupled with 
genetic counseling, to reduce the burden of KS in Iran.    
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Oxidative stress and mitochondrial alterations in Kindler Syndrome 
S Guerrero-Aspizua,2 Z Elisabeth,2 JL García-Giménez,1 M García,2 CJ Conti,2 F Larcher,2 
FV Pallardó1 and M del Río2 1 Physiology, Fundación Investigación Hospital Clínico 
Universitario de Valencia, Instituto de Investigación INCLIVA, Valencia, Spain and 2 
Bioengineering, Unidad Mixta UC3M-CIEMAT. CIBERER, Madrid, Spain
Kindler Syndrome (KS) (OMIM 173650) is an autosomal recessive skin disorder caused by mutations 
in FERMT 1 and characterized by skin blistering, photosensitivity, premature aging and skin cancer 
predisposition. However, the known functions of FERMT1, involved in cell adhesion, do not suffice 
to fully understand the pleiotropic nature and clinical variability of this genodermatosis. Some of 
these pathognomonic features of KS not related to cutaneous fragility, such as premature skin aging 
and cancer predisposition, have been strongly associated with oxidative stress. Mitochondrial oxi-
dative stress has long been implicated in both, aging and cancer. During oxidative phosphorylation, 
reactive oxygen species (ROS) are generated as by-products and its accumulation results in DNA 
damage as well as increased cancer susceptibility. We have explored the potential role of mito-
chondria-derived oxidative stress on the pathogenesis of KS. For that purpose we studied different 
biomarkers of oxidative stress in cells from KS patients. Patient-derived keratinocytes showed an 
altered oxidative status as demonstrated by increased glutathione and malondialdehyde levels and 
by a highly sensitive chimerical redox biosensor system. The ultrastructural analysis of KS skin biop-
sies and keratinocytes revealed striking abnormalities in mitochondria. In addition, keratinocytes 
from KS patients showed a reduced and diffuse MitoTracker Red staining and a significant reduction 
of the membrane potential. Overall, our data indicate that mitochondria in KS are not only altered 
in structure, but also in their distribution and functionality. This is the first study to demonstrate that 
mitochondrial dysfunction and oxidative stress contribute to the etiology of KS.    
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Regulation of IL-33 expression by normal human epidermal keratinocyte
H Tsuda,1 M Komine,1 T Ohshio,1 S Tominaga2 and M Ohtsuki1 1 Dermatology, Jichi Medical 
University, Shimotuke, Japan and 2 Biochemistry, Jichi Medical University, Shimotuke, Japan
IL-33 is a member of the IL-1 family, and important to adaptive Th2 immunity. We previously 
reported that IFNγ induced expression of IL-33 in normal human epidermal keratinocytes (NHEKs). 
On the other hand, it has been reported that IFNγ did not induce IL-33 in monocyte, while TNFα 
and IL-1β did. Recently mouse IL-33 (mIL33) has been revealed to have two distinct transcripts with 
different non-coding exon1, both of which code the same protein sequences. We have confirmed 
that there were three different transcription products of IL-33, each containing one of three distinct 
exon1s, i.e., exon1a, 1b and 1c. We speculated that each exon1 has its own promoter region, 
which may be regulated in cell type- and stimulus-dependent manner. We aimed to clarify the 
differential usage of three distinct promoters containing each exon1 in different types of cells, with 
various stimuli. We amplified approximately 2.5 kbp region of the 5’ UTR of each three exon1 
with PCR and cloned them into upstream of firefly luciferase gene construct. These constructs were 
transfected to NHEKs, human umbilical endothelial cells (HUVECs) and normal human dermal fibro-
blasts (NHDFs), stimulated with IFNγ or TNFα, and luciferase assay was performed. The construct 
containing 5’ UTR of exon1b had high luciferase activity without stimulation in NHEKs, HUVECs, 
and NHDFs. It strongly responded to IFNγ, but did not respond to other stimuli investigated, such 
as TNFα, IL-1β and LPS for TLR4 ligand in NHEKs and HUVECs. In NHDFs, exon1b containing 
promoter construct did not respond to any stimuli investigated. Other constructs containing 5’ UTR 
of exon1a or exon1c, showed only very weak luciferase activity, which did not respond to any 
stimuli investigated. We identified an active promoter of hIL33. The regulation of IL-33 transcription 
in NHEKs, HUVECs, and NHFDs may depend on the same promoter, which may utilize common 
transcription factors.    
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Reversion-triggered release of confined lethal mutations: an unreported genetic pathogenesis
Y Ogawa,1 T Takeichi,1 M Kono,1 N Hamajima,2 T Yamamoto,3 K Sugiura1 and M Akiyama1 
1 Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, 
Japan, 2 Department of Healthcare Administration, Nagoya University Graduate School 
of Medicine, Nagoya, Japan and 3 Department of Legal Medicine and Bioethics, Nagoya 
University Graduate School of Medicine, Nagoya, Japan
Loss of gene functions due to nonsense mutations is a typical pathogenic mechanism of hereditary 
diseases. They may, however, in certain genetic contexts, confine the effects of other dominant 
pathogenic mutations. Theoretically, reversion of such disease-confining mutation may elicit a 
disease, like the opening of Pandora’s box, although no actual case have been reported. We report 
the first instance in the literature where the reversion of a “confining” nonsense mutation in GJB2 
gene released the dominant pathogenic effect of a coexisting gain-of-function mutation, eliciting the 
lethal keratitis-ichthyosis-deafness (KID) syndrome. We encountered a KID syndrome patient who 
had a heterozygous missense mutation p.Gly45Glu in GJB2 gene. Unexpectedly, her healthy mother 
also had the heterozygous missense mutation p.Gly45Glu, as well as another heterozygous nonsense 
mutation p.Tyr136X (Ogawa et al., PLoS Genet. 2014). The biological relationship between the 
parents and the child was confirmed by genotyping of 15 short tandem repeat loci. We performed 
haplotype analysis using 40 SNPs spanning the >39 kbp region surrounding the GJB2 gene to find 
that an allelic recombination event involving the maternal allele carrying the mutations generated 
the pathogenic allele unique to the patient. Previous reports and our mutation screening support 
that p.Gly45Glu is in complete linkage disequilibrium with p.Tyr136X in the Japanese population. 
Estimated from statistics in the literature, more thane 10,000 p.Gly45Glu carriers in the Japanese 
population are protected from the disease by this second-site mutation. The reversion-triggered 
onset of the disease shown in this study is a previously unreported genetic pathogenesis based on 
Mendelian inheritance.    
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Selection of antisense oligonucleotides for trans-splicing enhancement using a fluores-
cence-based screening system
U Koller, S Hainzl, C Hüttner, T Kocher, A Klausegger, EM Murauer, C Gruber, E Mayr, 
V Wally and JW Bauer Department of Dermatology, Division of Experimental Dermatology 
and EB House Austria, Paracelsus Medical University, Salzburg, Austria
RNA trans-splicing is a promising tool for RNA repair in genetic diseases. The RNA trans-splicing 
process is induced by RNA trans-splicing molecules (RTMs) via specific binding of the respective 
target pre-mRNA region. To accelerate RTM design we have established a reporter-based screening 
system which allows us to analyse the impact of defined factors on the RTM trans-splicing efficiency 
in vitro. Using this screening system we are able to analyse the potential of antisense oligonucle-
otides (ASOs) to improve the trans-splicing capacity of a selected RTM, specific for intron 102 of 
COL7A1. Defects in collagen type VII encoded by COL7A1 are associated with the dystrophic form 
of the skin blistering disease epidermolysis bullosa (DEB). A selected ASO, which interferes with 
the competitive splicing elements on a stable expressed COL7A1-minigene (COL7A1-MG), was 
co-transfected with a highly functional RTM into HEK293 cells leading to a significant increase 
of the RNA trans-splicing efficiency. Thereby, accurate trans-splicing between the RTM and the 
COL7A1-minigene is represented by the restoration of full-length acGFP, quantified on mRNA and 
protein level. We assume that this observation can improve the RTM-mediated correction of genes 
on mRNA level, especially in cases where a high trans-splicing efficiency is required.    
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SNEV hPrp19/hPSO4 haploinsufficiency accelerates premature skin aging in response to 8-methoxy-
psoralen/UVA treatment in mice
R Monteforte,2 G Beilhack,3 R Grillari-Vogelauer,4 M Sibilia,5 E Tschachler,6 F Gruber7 and 
J Grillari1 1 Department of Biotechnology, Christian Doppler Laboratory on Biotechnology 
of Skin Aging, University of Natural Resources and Applied Life Sciences, Vienna, Austria, 2 
Department of Biotechnology, University of Natural Resources and Applied Life Sciences, 
Vienna, Austria, 3 Division of Nephrology & Dialysis, Internal Medicine III, Medical University 
of Vienna, Vienna, Austria, 4 Evercyte GmbH, Vienna, Austria, 5 Institute for Cancer 
Research, Medical University of Vienna, Vienna, Austria, 6 Department of Dermatology, 
Medical University of Vienna, Vienna, Austria and 7 Department of Dermatology, Christian 
Doppler Laboratory on Biotechnology of Skin Aging, Medical University of Vienna, Vienna, 
Austria
Senescent cells accumulate during aging in various tissues and contribute to organismal aging. 
However, factors that are involved in the induction of senescence in vivo are still not well under-
stood. SNEVhPrp19/hPSO4 is a multifaceted protein, known to be involved in DNA damage repair, 
including interstrand cross link (ICL) repair, and senescence, albeit only in vitro. In this study we 
used heterozygous SNEV+/- mice (SNEV knock-out results in early embryonic lethality) and wild type 
littermate control mice as a model to elucidate the role of SNEVhPrp19/hPSO4 in DNA damage repair 
and senescence in vivo. We performed PUVA treatment, consisting of 8-methoxypsoralen (8-MOP) 
in combination with UVA on mouse skin to induce DNA damage - prevalently ICL - and premature 
skin aging. We show that SNEVhPrp19/hPSO4 expression decreases during organismal aging, while p16, 
as marker of aging in vivo, increases. In response to PUVA treatment on the skin of old SNEV+/- 
mice, we observe increase of γ-H2AX level, as DNA damage marker, accompanied by reduced 
epidermis thickening, increase of p16 level as well as loss of structure accompanied by increase in 
MMP1 levels. Thus, the DNA damage response occurring in the mouse skin upon PUVA treatment 
is dependent on SNEVhPrp19/hPSO4 expression and lower levels of SNEV result in accumulation of 
DNA damage, increase of cellular senescence and thus in acceleration of premature skin aging.   
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Splicing regulation disturbances in psoriasis pathogenesis 
E Szlávicz,1 K Szabó,1 Z Bata-Csorgo,1 A Bebes,1 L Francziszti,1 A Dobozy,1 G Groma,1 
L Kemény1 and M Széll2 1 Department of Dermatology and Allergology, University of 
Szeged, Szeged, Hungary and 2 Department of Medical Genetics, University of Szeged, 
Szeged, Hungary
In a recently performed cDNA microarray experiment we identified three splicing regulators (serine/
arginine-rich splicing factor 18 (SFRS18), peptydilpropyl isomerase G (PPIG), luc-7 like3 (LUC7L3) 
that where differentially expressed in response to T-lymphokines in healthy and psoriatic non-in-
volved epidermis samples. We and others have previously shown that the oncofetal splice variant 
of fibronectin - the isoform containing the EDA domain (EDA+) - is overexpressed in psoriatic 
non-involved epidermis. In this study we investigated whether SFRS18, LUC7L3 and PPIG are 
able to alter the ratio of the normal (EDA-) and psoriasis-associated (EDA+) variant. To this aim the 
expressions of the splicing regulators were silenced in immortalized keratinocytes (HPV-KER). We 
found that the EDA+/EDA- ratio was altered upon silencing of LUC7L3 and PPIG: before silencing 
the expression level of EDA+ fibronectin isoform was higher than the EDA- fibronectin, but as a result 
of silencing the amount of the two splice variants became comparable. In addition, the expression 
patterns of the splicing regulators were compared in two different synchronized, immortalized cell 
lines, HaCaT and HPV-KER cells. Gene and protein expression patterns of the three regulators were 
very similar in both cell lines during their proliferation and differentiation suggesting that they may 
share common regulation.    
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Striking intrafamilial phenotypic variability in loricrin keratoderma
S Suzuki,1 T Nomura,1 Y Fujita,1 W Nishie,1 M Akiyama2 and H Shimizu1 1 Department 
of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan and 
2 Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, 
Japan
Loricrin keratoderma (LK) is an autosomal dominant disorder of keratinization, characterized by the 
presence of distinct heterozygous mutations in the loricrin gene (LOR). To date, only 11 families with 
LK have been reported. Common clinical features of LK include diffuse palmoplantar keratoderma 
(PPK) with honeycomb pattern (HCP), generalized ichthyosis and pseudoainhum. Some LK patients 
showed erythroderma, clinically diagnosed as having congenital ichthyosiform erythroderma (CIE). 
One family with LK developed non-migrating hyperkeratotic erythematous plaques, with a clinical 
diagnosis of progressive symmetrical erythrokeratoderma. Thus, LK patients show wide interfa-
milial clinical variability. However, the clinical features of LK are not yet fully understood, due to 
the scarcity of LK families. In this study, we investigated a Japanese family with LK. A proband, a 
36-year-old man, exhibited generalized dry, scaly skin from birth. He also showed non-migrating 
scaly reddish plaques on the chest and limbs. Reticular erythema was evident on his trunk. He 
showed PPK, but without HCP or pseudoainhum. The absence of family history initially led us to 
a diagnosis of CIE. Several years later, he fathered two daughters, both of whom also developed 
generalized mild ichthyosis. Notably, they showed HCP-PPK and mild pseudoainhum. A diagnosis 
of LK was made by exome and Sanger sequencing, which identified a heterozygous LOR mutation, 
c.545_546insG. Our findings suggest that the absence of HCP-PPK and/or pseudoainhum does not 
exclude the possibility of LK and that the presence of PPK and generalized ichthyosis indicates a 
possible diagnosis of LK. Our results also indicate that patients with LK can show striking intrafamilial 
clinical variability, even when carrying the same mutation. Moreover, we show that LK patients 
can develop reticular erythema, which had not been described previously. These results provide 
further phenotypic insights into LK.    
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The effect of two endogenous retinoids on the mRNA expression profile in human primary 
keratinocytes, focusing on genes causing autosomal recessive congenital ichthyosis 
H Törmä, A Bergström, G Ghiasifarahani and B Berne Medical Sciences/Dermatology, 
Uppsala University, Uppsala, Sweden
Retinoids (natural forms and synthetic derivatives of vitamin A) are used as therapeutic agents 
for numerous skin diseases, such as keratinization disorders (e.g. ichthyoses) and psoriasis. Two 
endogenous ligands for retinoic acid receptors exist, retinoic acid (atRA) and 3,4-didhydroretinoic 
acid (ddRA). In primary human epidermal keratinocytes many transcriptional targets for atRA are 
known, whereas the targets for ddRA are unknown. In an attempt to determine the targets we com-
pared the effect of atRA and ddRA on transcriptional profiles in undifferentiated and differentiating 
keratinocytes. First, as expected, many genes were induced or suppressed in response to keratinocyte 
differentiation. Furthermore, the two retinoids affected substantially more genes in differentiated 
keratinocytes (>350) than in proliferating keratinocytes (≈ 20). In differentiating keratinocytes mark-
ers of cornification were suppressed suggesting a de-differentiating effect by the two retinoids. When 
comparing the expression profile of atRA to that of ddRA no differently regulated genes were found. 
The array analysis also found that a minor number of miRNAs and a large number of non-coding 
transcripts were changed during differentiation and in response to the two retinoids. Furthermore, 
the expression of all, except one, genes known to cause autosomal recessive congenital ichthyosis 
(ARCI) were found to be induced by differentiation. These results comprehensively document that 
atRA and ddRA exert similar transcriptional changes in keratinocytes and also add new insights into 
the molecular mechanism influenced by retinoids in the epidermis. Furthermore, it suggests which 
ARCI patients that could benefit from therapy with retinoids.    
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The transcription factor FOSL1 and its role in psoriatic lesional skin 
A Zolotarenko, A Mezentsev, A Soboleva and S Bruskin Functional Genomics, Federal Non-
profit Research Institution of Russian Academy of Sciences, NI Vavilov Institute of General 
Genetics, Moscow, Russian Federation
The gene that encodes the transcription factor FOSL1 is upregulated in lesional psoriatic skin and 
downregulated in the period of disease remission after the patient finished a course of PUVA. The 
aim of this study was to explore the role of FOSL1 in psoriasis via identification of FOSL1 target genes 
in lesional psoriatic skin. Next generation sequencing technique (NGS) was used to identify differ-
entially expressed genes. Immunohistochemistry was used to detect FOSL1 in psoriatic skin lesions. 
Bioinformatics approaches were used to identify FOSL1 target genes. The ability of RAGE ligands 
to induce the identified FOSL1 target genes was verified by stimulation of epidermal keratinocytes 
(HaCaT) with the named proinflammatory factors. The immunohistochemistry results confirmed the 
activation of FOSL1 in psoriatic skin lesions. The NGS analysis revealed that the following FOSL1 
target genes, namely CCL2, CCND1, FOSL1, HMOX1, IL8, IVL, MGP, MMP1, MMP9, and PLAUR 
were differentially expressed in the plaques. In addition, we were able to induce some of the named 
genes by a treatment of HaCaT with the proinflammatory factors S100A7-S100A7 and S100A8-
S100A9. We conclude that the transcriptional regulator FOSL1 can be involved in pathogenesis of 
psoriasis for two reasons. First, the certain FOSL1 genes were differentially expressed in lesional 
skin. Second, the proinflammatory factors, namely S100A7-S100A7 and S100A8-S100A9 dimers 
were able to induce the certain FOSL1 target genes the in vitro model that was often used to imitate 
of human hyperproliferative epidermises. We suggest targeting FOSL1 and FOSL1-controlled genes 
as a new therapeutic approach for psoriasis.    
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The up regulation of ABCA1 by the activation of LXRβ and PPARδ/γ to renew archetypical 
differentiation in Harlequin Ichthyosis
P Bland, B Fell and D Kelsell Centre for Cutaneous Research, Blizard Institute of Cell and 
Molecular Science, Queen Mary, University of London, London, United Kingdom
Harlequin Ichthyosis (HI) is the most severe and frequently fatal form of congenital ichthyosis. In 
2005, we discovered that recessive mutations in ABCA12, a keratinocyte transporter, were caus-
ative in HI. Loss of ABCA12 leads to defective transport of glucosylceramide into lamellar bodies, 
impaired transportation of proteases, premature terminal differentiation and retention of squames, 
leading to skin with thick hyperkeratotic plates characteristic of the HI phenotype. We have found 
via gene expression array data, that transcription of the cholesterol transporter ABCA1 is down 
regulated after ABCA12 shRNA ablation of transcript. Additionally, through Ingenuity Pathway 
Analysis we hypothesized that the down regulation of ABCA1 may be due to a dysregulation of 
the nonsteroidal nuclear hormone receptors, the liver X receptor (LXR) and the peroxisome prolif-
erators-activated receptors (PPARs). Activation of LXRβ and PPARδ/γ has been previously shown to 
increase transcription of ABCA1. We confirmed the down regulation of ABCA1, LXRβ and PPARδ/γ 
using immunohistochemical analysis of a HI patient biopsy and western blot analysis of keratinocytes 
that had undergone ABCA12 siRNA knockdown. We have developed and characterised a HI cell 
line, which displays terminal differentiation markers prematurely under calcium shift and in the 
organotypic 3D cultures, which also presented with a thickened stratum corneum. The application 
of PPARδ/γ and even more so LXRβ agonists facilitate an increase of ABCA1 expression in the patient 
derived HI cell line. These possible therapeutic strategies could aid cholesterol transportation in 
the epidermis, crucial in permeability barrier formation and in turn the movement of desquamation 
proteases to the stratum corneum.    
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Transcriptome Analysis of Psoriatic Epidermis
MH Tervaniemi,2 S Katayama,3 A Siitonen,1 S Suomela,1 J Vuola,4 T Skoog,3 S Linnarsson,3 
J Kere3 and O Elomaa2 1 University of Helsinki, Helsinki, Finland, 2 University of Helsinki, 
Helsinki, Finland, 3 Karolinska Institutet, Stockholm, Sweden and 4 Helsinki University 
Central Hospital, Helsinki, Finland
Split thickness skin grafts (STSG), consisting mainly of the epidermis and only a small amount of 
dermis, were taken from 9 healthy control (C), 5 psoriatic non-lesional (PN), and 6 lesional (PL) 
patients and subjected to RNA 5’-end sequencing. Total RNA per cell in PL was higher than in the 
C and PN samples; the data, therefore, was analyzed by using RNA spike-in normalization instead 
of global normalization. We found only 35 differentially expressed transcripts (DETs) in the PN skin 
when compared with the controls (FDR < 0.05). 28 of these were up-regulated (FC > 1.5) and only 7 
down-regulated (FC < 0.75). Interestingly, 12 of the DETs map to the known PSORS loci, of which 
PSORS4 was the most represented among the up-regulated ones. 2437 and 3541 transcripts were 
up-regulated and 2550 and 491 down-regulated in the PL, when compared with the C and PN sam-
ples, respectively. Gene set enrichment analysis with the differentially expressed genes (DEG) in PL, 
revealed enrichment at the PSORS4 locus. The functional annotation analysis of DEGs highlighted 
gene ontology groups related to keratinocyte and epidermal cell differentiation, already in the PN 
samples. Furthermore, PL-DEGs showed enrichment in many of the functional groups previously 
associated with psoriasis: e.g. innate immunity and cell adhesion. Comparison of our STSG DEGs 
with the previous gene expression data from full thickness (FT) psoriatic samples shows consid-
erably less down-regulation, which may be due to the high amount of dermis in the FT samples; 
the expansion of epidermis in psoriasis leads to decrease in dermal genes. These results indicate 
that our samples enable direct focusing mainly on the epidermal transcripts. RNA-Seq also enables 
the identification of different start sites and transcripts from the introns and untranslated regions. 
In addition, the sensibility allows a more concrete recognition of the altered signaling pathways.   
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Ultrastructural abnormalities in exfoliative ichthyosis with a novel mutation in CSTA 
R Gruber,1 V Moosbrugger-Martinz,1 A Jalili,2 AS Schossig,3 G Stingl,2 J Zschocke,3 
M Schmuth1 and H Hennies3 1 Department of Dermatology, Innsbruck Medical University, 
Innsbruck, Austria, 2 Department of Dermatology, Medical University of Vienna, Vienna, 
Austria and 3 Division of Human Genetics, Medical University Innsbruck, Innsbruck, Austria
Recently, mutations in CSTA, encoding the cysteine protease inhibitor A, which seems to be critical 
in desmosome-mediated cell-cell adhesion within the lower epidermal layers, were identified as 
the genetic cause of autosomal-recessive exfoliative ichthyosis (AREI). AREI is characterized by 
diffuse palmoplantar hyperkeratosis and coarse skin peeling of the hands, feet and distal extremities 
without blisters, and often mediated by humidity. We performed ultrastructural analysis by transmis-
sion electron microscopy, including ruthenium tetroxide postfixation in a 25-year-old patient with 
AREI, who exhibited the unknown homozygous loss-of-function mutation c.172C>T (p.Arg58Ter) 
in CSTA. Ultrastructural features included normal degradation of corneodesmosomes, mild inter-
cellular oedema in the spinous layer but not in the basal layer, normal appearing desmosomes, 
and prominent keratin filaments within the basal keratinocytes. Thickness of cornified envelopes 
was reduced, and epidermal barrier abnormalities were characterized by abnormal lamellar lipid 
bilayers in the stratum corneum, with non-lamellar electron-dense material and vesicular contents, 
premature and inhomogeneous lamellar body secretion and delayed processing of secreted lamellar 
body contents. Barrier abnormalities were reminiscent, albeit less severe, of Netherton syndrome 
(NS), which results from deficiency of serine protease inhibitor LEKTI. Accelerated proteolysis of 
corneodesmosomes in NS is caused by an imbalance in kallikreins and leads to ichthyosiform 
erythroderma and atopic manifestations. This work expands the morphological features and provides 
evidence of epidermal barrier abnormalities in AREI.    
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Whole-exome sequencing reveals genetic modifiers associated with elevated IgE and allergic 
sensitization in ichthyosis
D Kiritsi,1 M Valari,2 P Fortugno,3 I Hausser,4 L Lykopoulou,2 G Zambruno,5 L Bruckner-
Tuderman,1 T Jakob1 and C Has1 1 Dermatology, Medical Center-University of Freiburg, 
Freiburg, Germany, 2 Agia Sofia Children’s Hospital, University of Athens, Athens, Greece, 3 
Dermatology Unit, Bambino Gesù Children’s Hospital, Rome, Italy, 4 Institute of Pathology, 
University Clinic Heidelberg, Heidelberg, Germany and 5 Laboratory of Molecular and 
Cellular Biology, Istituto Dermopatico dell’ Immacolata, Rome, Italy
The crucial role of the skin as a barrier is mainly dependent on terminally differentiated kerati-
nocytes, the corneocytes, which are dynamically and regularly desquamated, so that the stratum 
corneum becomes repopulated by new cells. Numerous molecular players govern these processes, 
and mutations in the corresponding genes result in ichthyoses, characterized by generalized skin 
scaling. Using whole-exome sequencing, we performed a comprehensive genetic analysis in a young 
male displaying a keratinization disorder with episodes of dermatitis, allergic sensitizations and high 
IgE levels, without specific histopathologic and ultrastructural features. We show that besides the 
NIPAL4 mutation c.527C>A, p.A176D which caused the ichthyosis, additional disease modifying 
variants in the genes encoding LEKTI and filaggrin contribute to the distinct allergic manifestations. 
Importantly, although the variants, p.E420K and p.S368N in LEKTI, and p.P478S in filaggrin, have 
been associated with atopic dermatitis in large-scale studies, they did not cause any cutaneous 
disease in the parents or siblings of our patient, but became relevant modifiers only in the context of 
the major keratinization defect present in the patient. Our findings support the idea that a complex 
interplay exists between mutations and functional variants in genes for proteins involved in epider-
mal differentiation, resulting in a spectrum of barrier function defects and allergic manifestations.    
   
      
      
